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Facial implants are becoming more common in America and across the world.  In 
the United States last year, over 260,000 augmentation and reconstruction surgeries were 
performed on facial cartilage areas, while over two million soft tissue fillers were 
administered.  The current implants on the market, though, are deficient in three major 
areas: they are too rigid, susceptible to migration, and require a large incision.   
Alternatively, dermal fillers lack shape and biodegrade too quickly. Poly(vinyl) alcohol 
(PVA) cryogel is a promising hydrogel alternative due to its softness, durable nature and 
ease of cast molding.  While biocompatible, it does not elicit a fibrous response with firm 
adhesion and could migrate.  The goal of this study is to develop a biodurable implant 
material that has soft-tissue elasticity, pores for adhesion, and swelling for small 
incisions. 
 In this research, multiple porosity inducing methods are applied to PVA cryogel.  
These include a casting PVA cryogel over a porogen then leaching it in a solvent, a 
gaseous exothermic reaction, creating composites with biodegradable components, as 
well as using molds to alter the surface texture.  Once created, the samples then 
underwent a series of tests to determine their mechanical properties which include 
elasticity, tensile strength, elongation, tear strength, pore size, and porosity.  Swelling 
ratio of nonporous PVA cryogel was also considered. 
Porous PVA cryogel made with a high PVA weight percentage (30%) showed 
equivalent mechanical properties to that of cartilage.  Porous PVA cryogel manufactured 
with a lower weight percent (10% and 20%) were shown to have similar elastic properties 
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to that of adipose tissue.  The surface texture methods, gas method, casting and leaching 
method, and composites made with CaPO4 and chitosan were all shown to create pores 
large enough for ingrowth. Samples created with a porosity large enough to encourage 
ingrowth include the gas method, casting and leaching method, and the CaPO4 
composites.  The swelling ratio was shown to increase as the weight percentage of PVA 
in the samples decreased.  These quantified characteristics can be used to select the 












The purpose of prosthetics is to replace portions of damaged or missing body 
parts in order to improve physiological function and/or appearance.  With this purpose in 
mind, volume filling implants were examined to determine whether there was a need for 
improvement in any category.  After reviewing current products on the market, facial 
implants arose as a promising field.  In 2013, over 260,000 augmentation and 
reconstruction surgeries were performed on facial cartilage areas.  Many biomaterials are 
currently on the market for this purpose, however each has issues including rigidity and a 
tendency to migrate.  In addition, over two million soft tissue fillers were administered 
last year.  Most of these fillers, however, are only temporary.  The one brand that is 
permanent is made up of microspheres that, if they become infected, can lead to scaring 
and disfigurement.     
Poly(vinyl) alcohol (PVA) cryogel has emerged as a new biomaterial for 
prosthetic implants.  Its characteristics include biocompatibility, high water solubility, 
resistance to degradation within the body, and the ability to mimic a wide range of 
characteristics similar to soft tissues.[1, 2]  Its softer nature in comparison to current 
biomaterials will allow it to feel more natural underneath the skin.  It is currently used in 
an array of medical products from vein valves to soft contact lenses.[1]   Its application 
towards volume filling implants could be limited however because of its nonporous 
2 
 
structure within the body.  This may lead to lack of adhesion to the body and subsequent 
migration of the implant. 
In this study, one pathway to promote implant adhesion was examined – the 
manufacture of pores at the surface and throughout the implant.  Porosity inducing 
techniques were applied to PVA cryogels in order to create open and closed cell pores.  
The purpose is to determine which methods are feasible as well as characterize key 
mechanical properties of the manufactured porous PVA cryogel.  These properties 
include elasticity, tensile strength, tear strength, elongation percentage, pore size, 
porosity percentage, and swelling ratio.  These values were quantified to provide a 
reference database when designing volume filling implants with porous PVA cryogels.  
3 
 
Choosing Volume Filling Facial Implants 
The goal is to research volume filling implants to determine one that could be 
improved or enhanced with PVA cryogel.  Through the FDA’s list of implantable 
devices[3], 18 types of space occupying implants were identified.  These are listed in  
Table 1 with a description, prevalence, and usage of each type of implant.  The 
prevalence data were obtained from the American Society of Plastic Surgery[4] and are 
for the Unites States only.   
The categories on Table 1 were narrowed down to determine which implants 
would be the most feasible for PVA cryogel.  Since PVA cryogel's mechanical 
characteristics cannot be made to mimic that of bone, categories intended for bone 
replacement such as JAZ (mandibular implant facial prosthesis composed of materials 
such as stainless steel and titanium) were excluded.  MIC (pectoral muscle implant) was 
removed because of such a small implantation rate in comparison to other implants.  
Since PVA cryogel is a hydrogel, it must always be hydrated.  Implants that have contact 
with the air such as ESZ (endolymphatic shunt) and HPZ (eye sphere implant) were 
excluded because the PVA cryogel would dehydrate and shrink.  While MRD (breast 
implant) is one of the most common augmentation implants with 290,000 operations in 
2013, thus about 680,000 breast implants[4], the Class III regulation pathway required by 
the FDA is lengthy, complicated, and expensive.[5] 
With function, material, prevalence, implantation area, and regulatory pathway 
taken into account, facial implants arose to be a favorable and promising choice for PVA 
cryogel implants.  These include categories FWP (internal chin prosthesis), FZE (internal 
nose prosthesis), MIB (facial silicone block), and LMH (wrinkle filler).  These implants 
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were extensively researched to determine the tissue's physiological characteristics; a 
series of experiments were conducted to see whether PVA cryogel can meet these 
conditions and become a more suitable material for these implants than those currently 
sold on the market.  It is hypothesized that PVA cryogel can be substituted for the current 




Table 1: List of FDA's Volume Filling Implant Categories 
References [3, 4, 6] 
 





General & Plastic Surgery, 
ENT
For plastic and reconstructive surgery 
of soft tissue deformaties of chin, jaw, 
nose, or bones or tissue near the eye 
or ear.  Shaped and formed by 
surgeon
Ceravital ceramic ear canal wall 
prosthetic, Hearing aid
Polytetraflouroethylene with carbon fibers composite
Hard to determine because it 





Synthetic polymer material (Polymer, 
Synthetic-Pife, Silicon Elastomer, 
Polyethylene, Polyurethane)
Ear Nose & Throat Space occupying substance
Nose, ear, chin, calf, gluteal, and 
pectorial implants. Closing defects 
in esophagus. Silicone blocks that 
can be shaped
Synthetic polymer material (Polymer, Synthetic-Pife, 
Silicon Elastomer, Polyethylene, Polyurethane)
Hard to determine because it 




Otoplasty (Ear) prosthesis General & Plastic Surgery For reconstruction of the external ear Ear Lobe Silicone rubber solid 24,000 in 2013
ESZ Endolymphatic shunt Ear Nose & Throat Used to relieve Ménière's disease
Tube that is inserted in 
endolymphatic sac
Polytetrafluoroethylene or silicone elastomer 100,000 cases a year
ETC Middle ear mold Ear Nose & Throat Repair of the tympanic membrane
Preformed device that is 
implanted to reconstruct the 
middle ear cavity
Polyamide, polytetrafluoroethylene, silicone 
elastomer, or polyethylene, but does not contain 
porous polyethylene
150,000 cases a year
FAE Penile rigidity implant Gastroenterology/Urology Erectile disfunction





Internal and temporal chin prosthesis General & Plastic Surgery
Augment or reconstruct the chin 
(Mentoplasty)
Chin Prosthesis Silicone rubber solid 20,000 in 2013
FZE Internal nose prosthesis General & Plastic Surgery
Augment or reconstruct the nasal 
dorsum (Rhinoplasty)
Nosal Prosthesis Silicone rubber solid 250,000 a year
GXO Preformed craniosynostosis strip Neurology
Prevents the bone from regrowing in 
patients whose skull sutures are 
abnormally fused together
Strip used to cover bone edges of 
craniectomy sites (sites where the 
skull has been cut) 
Plastic
HPZ Eye sphere implant Ophthalmic
Implanted in the eyeball to occupy 
space following the removal of the 
contents of the eyeball
JAZ Mandibular implant facial prosthesis Ear Nose & Throat
Functional reconstruction of 
mandibular (lower jaw bone) defects
Stainless steel, tantalum, titanium, cobalt-chromium 
based alloy, polytetrafluoroethylene, silicone 
elastomer, polyethylene, polyurethane, or 
polytetrafluoroethylene with carbon fibers composite
KHK Polymer, Ent Natural-Collagen Material Ear Nose & Throat Collagen
KIG Wrist joint polymer constrained prosthesis Orthopedic For replacement of a wrist joint
Consists of a single flexible across-
the-joint component that prevents 






Code Description Specialty Uses Examples Material Prevelance
LBL Porous polyethylene tympanostomy tube Ear Nose & Throat
For ventilation or drainage of the 
middle ear by permit a free exchange 
of air between the outer ear and 
middle ear
Malleous clip tube 
Polytetrafluoroethylene, polyethylene, silicon 
elastomer, or porous polyethylene
668,245 in 2006
MIC Implant, Muscle, Pectoralis General & Plastic Surgery Implanted under chest muscle Pectorial Implant Silicone rubber solid 342 in 2013
FWM 
FTR
Sizer, Mammary, Breast Implant Volume General & Plastic Surgery
Implanted under the breast tissue or 
under the chest muscle to increase 
breast size (augmentation) or to rebuild 
breast tissue after mastectomy or other 
damage to the breast (reconstruction).
Breast Implant
Saline-filled and silicone gel-filled. Both types have a 
silicone outer shell
290,000 in 2013
NRO Surgical Lip Implant General & Plastic Surgery All injectable are temporary  Polytetrafluoroethylene 25,000 in 2013
LMH Wrinkle filler General & Plastic Surgery
To fill in facial wrinkles or fat loss in 
order to create a smoother 
appearance. 
Many absorbable materials, but 
only one non-absorbable




To fill defects not intrinsic to the 
stability of the bony structure
Fills bony voids of the extremities, 
spine, and pelvis
Calcium SaltCalcium Salt Bone Void Filler Orthopedic
7 
 
Nose and Chin Replacements 
Facial implants are used for augmentation, correction of developmental or 
traumatic deformities, and to help improve the feature's functionality.   
Market Size 
In 2013, 19,000 chin implants were implanted within the United States.  While 
14% of the patients were in their twenties, the highest percent of patients were in the age 
bracket of 55 and older.  In addition, gender distribution was split.  51% of chin implants 
were administered to males while 49% were for females.[4] 
221,000 rhinoplasty procedures were performed in the United States in 2013, 
however it is not specified what percentage of these were for augmentation.  The most 
common age group for this procedure was the 20-29 year old range.  26% percent of 
rhinoplasties were performed on males while 74% was on females. [4] 
Regulatory Pathway 
The most basic volume filling implant category is MIB.  This category is defined 
as a synthetic polymer material meant for implantation for augmentation or 
reconstruction of the head and neck.[6]  It is a Class 2 device and requires a 510K 
pathway for clearance.  Its predicate devices range from basic silicone carving blocks to 
gluteal and calf implants.   
More specific facial implant categories are FWP (internal chin prosthesis) and 
FZE (internal nose prosthesis).  These are described as chin/nose prosthesis made of a 
silicone rubber solid device for augmentation or reconstruction.  Within their previously 
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cleared device summaries, there is a trend that they reference their own carving block 
made of equivalent material in MIB as a predicate device.  Once the basic material is 
approved, companies produce specific shapes and usages for it can be more easily passed 
through the FDA.  Also listed is a standard recommended by the FDA for submission: 
ASTM F881-94 (Standard Specification for Silicone Elastomer Facial Implants).  
Completing the standards set out for silicone should be considered when submitting 
porous PVA cryogel to the FDA.  These include determining tensile strength, elongation 
percentage, elastic modulus, and tear strength. 
Current Materials 
The three main types of implants are autographs (grafts derived from the patient's 
own tissue), homografts (where the tissue for the graft is from a donor), and alloplasts (in 
which the implants are completely or partially synthetic).[7, 8]  A summary of the main 
advantages and disadvantages between autografts, homografts, and allografts provided by 
Lin, et. al. and is shown in Table 2.[8]  A list of pros and cons specific to each material 
on the market is presented in Table 3.  
Table 2: Advantages/Disadvantages of Autografts, Homografts, and Allografts 
















Ridgid appearance to nose
Requires bone contact
Pain and scaring at donor signt
Gold standard of grafts
Sometimes not enough material for large defects, 
especially for trama or infection cases
Minimal resorption rate Chance of warping
Good vitality even with low blood supply





Redily available 10-20% reabsorption for dermis, 33-50% for fat
Good for small deformities Requires an extra surgery
Fibrous encapulation occurs and breaks it 
broken down to replace with host's collagen
Defect always returns to some degree
Injection (non surgical) 3% of patients sensitive to bovine collagen
Smoothing effect
Low rejection/reactivity rate
Injectable Initial mild foreign body reaction
Quite stable and practically inert in tissues
Fibrous encapsulation anchors in place
Inert, no reactivity Mild tissue reaction
Fibrous incapsulation High rate of extrusion, migration, infection
Safe, reliable implant Few reports of extrusion
Texture and firmness simulates soft tissue Moderate foreign body response
Fibrous incapsulation Some resorption after ~15 years, loss of use
No structural support
Extnesive fibroblast ingrowth makes almost 
impossible to remove
Highly porous (79%) but firm
Tendency to fragment and collapse under pressure 
and shear forces
Allows for host fibrous-tissue ingrowth Initial inflamatory response
Resistance of extrusion because filled with 
host tissue
Black substance, which may show through skin
No longer available in US
Easy to shape Less resistant to infection
Porous (46% of vol)
Rapid tissue/bone growth within a month
Very biocompatible Stiffness can create an unnatural appearance
Easily sculptable Rough surface makes insertion cumbersome
Minimal inflamation
Long term structural stability
Resistant to infection
High suscess in 2nd and 3rd revision surgeries
White in color
Enert
High rate of migration, extrusion, inflamation, 
calcification, patient disatisfaction
Easy to shape Feels like foreign body underneith skin
Thick fibrous incapsulation Slipery surface
Easy to remove Abnormal skin color, even after implant removal
Maintains its shape within body
Low tissue reactivity
Low cost Develop prominent edges over time
High biocompatibility Slippery, not easily carved
Microporous tissue ingrowth gives stability Recently discontinued in plastic surgery applications
Easily shaped Small pores increases liklyhood of infection
Can be removed without disrupting surroung 
tissue








Encourages bone growthBone graft
Cartilige graft
Frequently defective, insufficient, or missingSeptal Cartilage
Cartilage harvisted from 
patient
Cartilage harvisted from 
patient
Bone harvisted from 
patient
High resorption rate
Requires very large needle
Silastic organosilicone polymer
Easily shaped






















Proplast (I and II)
Prepared from Teflon 


















Autografts are regarded as the most preferred option for facial augmentation.  
Grafts are materials that are combined with a patient's own cartilage, bone, dermis, or fat.  
Its most important attribute is that it has extremely high biocompatibility.  They also 
provide strength and can be easily shaped.  Disadvantages include the potential for donor 
site morbidity, warping, and increased surgical time to obtain the extra material.  In 
addition, since it is made with the patient's own body, there is a chance of partial or full 
absorption of the biomaterials. There is also a risk of not enough supply of the biological 
components.  This is especially in the case of facial reconstruction where there is usually 
a shortage of donor sites from the body to achieve desired results.[7, 8] 
Bone 
The biomaterials from the bone grafts come from the rib, calvarium, iliac chest, 
and nasal septum.  Because this graft is made from a bone, it is much stiffer than 
surrounding facial tissue and is more likely to fracture than other grafts.  Noses 
reconstructed with these grafts tend to be more rigid and unnatural looking in appearance.  
They have lost favor over the years because of a high resorption rate and donor site 
morbidity which can include pain and paresthesia.[8]  In order to help prevent resorption, 
these grafts must have contact with bone.  If they are placed in contact with only soft 







Cartilage is currently the most commonly used material for autografts of facial 
implants.  It has a low infection and extrusion rate, as well as excellent elasticity and 
resistance.  It is easy for the surgeon to shape, survives in areas with low blood supply, 
and has a minimal resorption rate (as low as 2%).  The three sources for the graft come 
from septal, rib, and auricular cartilage with septal being the most preferred.  
Unfortunately, in the case of reconstruction and other forms of rhinoplasty, there is 
usually too little septal cartilage available. [13, 14] Like all autographs, an insufficient 
amount of cartilage will prevent it from being an option to surgeons.  Cartilage from the 
rib is almost always in large supply and offers great structural support, however there is a 
risk of potential donor site morbidities that include scar visibility and chest wall 
deformity.  Rib grafts also have a high rate of warping and must be added deeper under 
the skin than other cartilage grafts.[8] Unlike bone grafts, cartilage grafts do not require 
contact with bone or other cartilage to survive.  This allows them to be used in many 
more corrective surgeries because they do not need to be buried deep within the face.[11, 
15] 
Fat 
Fat is appealing because of the wide availability, however its absorption rate 
ranges anywhere between 20 and 90%.[16]  Because of this, it is typically used as a filler 
for small imperfections.  It is commonly paired with liposuction surgeries where some fat 





Homografts have long term unpredictability making them not an preferred 
substitute for autogenous grating material.  Because they are not made with the patient's 
own cells, homografts typically have a higher absorption rate (33%) and revision surgery 
rate (44.4%) than autografts.[8]  There is also the fear of transmitting diseases from the 
donor to the patient as well as a chance of extrusion.  To help prevent the transmission of 
diseases, donor bodies must comply with rigorous standards as well as the donated tissue 
is exposed up to 60,000 Gy gamma waves.[13]  This leads them to be offered at a higher 
cost to the patient.  They do, however, still have the same advantages of autografts like 
high biocompatibility, ability to be easily shaped, and easily camouflaged within the face.  
In addition, there is no donor site morbidity to the patient, reduced surgical time, and 
supply is no longer a limiting factor.  The most common biomaterial for homografts is 
irradiated costal cartilage (ICC).  This, unfortunately, has a high likelihood of warping as 
well as an absorption rate of 75% over 10 years.[8, 17]  
Alloplasts 
Alloplasts are synthetic implants that provide strength, elasticity, and durability 
for the face.  They are readily available, and because they are not from the patient's own 
body there is no donor site morbidity, reduced trauma to the patient, and a decreased 
surgical time.  Unfortunately, since they are synthetic, they have higher extrusion and 
infection rate and typically cost more.  The biggest issue with alloplasts is the risk of 
incompatibility with the patient.  An immuno-responce can happen soon after surgery or 




Silicone appeared in the 1950s and was the first alloplast to have gained 
widespread use.  It is a polymer of silicone-oxygen chains that are crosslinked by methyl 
side groups.  The crosslinking determines its physical state in which increasing crosslink 
leads to decreased elasticity.  This allows it to be provided in a range of mechanical 
properties.  It is nonporous, inert, and does not decompose nor change its shape over 
time.[8, 11]  Because it is manufactured using a mold, it can be produced in any shape to 
allow customization for an individual's needs.[15]  Its physical properties allow it to give 
excellent structural support for a facial implant.  Its firmness makes it easy to sculpt but 
can make it feel foreign underneath the skin and can even cause bone erosion.[13]  
After implantation, silicone becomes surrounded by a thick capsule of fibrous 
tissue which give it poor anchoring within the body and does little to stop migration.[8]  
This barrier also prevents penetration of antibiotics in the case of infection.  In addition, it 
has been observed to discolor the skin near the implant which usually persists even after 
the implant has been removed. Within the nose it experiences constant movement and 
frequent midface trauma.  This, combined with only a thin soft tissue cover, leads to a 
high chance of movement and extrusion.[11] An example of silicone extrusion is shown 
in Figure 1. 
Ham et.al. reviewed 1500 cases of silicone implants and found 357 complications 
(20.8%).  Of those complications, 6.6% were due to infections, 18% were inserted 
incorrectly, 8.5% migrated, 7.5% extruded, and 62.4% discolored the patient’s skin.[18] 
Because of the high rate of complication, silicone has become widely abandoned by 
western cultures.[13] Although it has lost popularity in America, it is still widely used in 
Asian countries because of its low cost in comparison to other alternatives.  In this 
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population, the patient's skin also tends to be thicker which reduces the extrusion rate of 
the implant.  The complication rate is still estimated around 10-16% within this 
ethnicity.[8, 10]  
 
Figure 1: Extruding Silicone Implant 
Medpor 
Medpor is a porous high density polyethylene produced by Stryker and is 
described in literature as safe and effective[10, 19, 20].  It is considered one of the stiffer 
options for implants and is commonly used in surgeries that add more support for facial 
features.[21]  It has been noted that its stiffness gives an unnatural appearance for more 
prominent features like the nose and its rough surface makes displacement infrequent but 
insertion into the face a cumbersome task.[13] When heated between 90-100°C, this 
material can be easily shaped, cut, pierced, and sutured.  Its shape becomes permanent 
when cooled.[14]  Its pore size ranges in between 100 and 250 µm, which is an optimal 
range for rapid fibrovascular ingrowth.[8]  This size is also large enough for the immune 
system to be effective which reduces its rate for infection and extrusion in comparison to 
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other porous implants.  It has been shown to have ingrowth of soft tissue within the 
implant after one week and bone after three.[10, 15]  Romo et. Al.[22] found a 
complication rate of 2.6% after implantation of Medpore into 187 patients.  While 
extrusion was the main complication, it was noted that those who experienced extrusion 
had thinner skin because of their smoking habits.  
Gore-Tex 
Polytetraflorethylene (Gore-Tex) is a microporous plastic material with a soft, 
textile feel that is more commonly used for volumetric compensation of smaller defects 
than support.  It is very pliable and is manufactured in sheets of variable thickness in 
which the surgeon can easily cut and carve for the desired shape.[14] It contains 
micropores with  sizes ranging from 10 to 30 µm.  The pores are large enough to give 
limited collagen ingrowth and graft stabilization to prevent movement and encourage 
minimal capsule formation to allow easy removal that will not disrupt the surround 
tissues. The small pores do, however, limit the immune system's effectiveness.[8] 
While Gore-Tex has been shown to have high biocompatibility and a minimal 
foreign body response, there is a chance of it slightly deforming and developing 
prominent edges over time as well as infection.[13]  Godin et al. [23] reviewed Gore-Tex 
4 years after implantation and found that 3.2% of the implants were infected and required 
removal.  Jin et al. [24] found a 2.5% complication rate of Gore-Tex due to infection in a 
group of 853 patients after 1.5 years.  Conrad et al. [25] examined 521 rhinoplasty 
patients who received a Gore-Tex implant over a span of 17 years.  They observed a 
complication rate of 3.4% and an implant removal rate of 1.9% with infection being the 
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main reason.  It is also important to note that it will always extrude if placed in contact 
with the dermis.[10]  While Gore-Tex sheets for general surgery are still being produced, 
its manufactures chose to discontinue its plastic surgery usage in 2006.[13] 
Supramid Mesh 
Supramid (polyamide mesh) was common in the 1970s and was considered the 
standard of its time.  It has a texture and firmness that is similar to soft tissue.  There 
were very little reports of adverse reactions and extrusion, and most of these were 
because of infection.  It caused some tissue reaction of macrophages and foreign-body 
giant cells, but that ceased within the year of implantation and became filled and 
surrounded by fibrous tissue that minimized the chance of migration.  It was more 
difficult to carve than other options.[11, 13]  By the mid 80s, however, it had almost 
completely been abandon by surgeons.  While it did show great initial results, it was 
discovered to fragment and degrade over time in the body.[8] This hydrolytic degradation 
was caused by the reversal of the polymerization reaction that forms the polymer.  This 
causes a gradual 20% loss of tensile strength per year of the material.  Within a decade, it 
is completely absorbed by the body.[8, 11] 
Mersilene Mesh 
Mersilene (polyethylene terephthalate) is the successor of Supramid.  It is a 
woven polyester fiber mesh produced by Ethicon, and is superior to Supramid mesh 
because it maintains its tensile strength, has minimal tissue reaction, and has little to no 
degradation within the body.[11]  Its average pore size is 125 µ.[26]  It is primarily used 
for volumetric correction because of its lack of structural support and has been shown to 
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not degrade nor absorb in the body over time.  Being made out of fiber, there is a large 
biological response in which it becomes filled with fibroblasts and ingrown with 
connective tissue.[14]  This makes it much more difficult to remove in the need of 
revision surgery which is required about 7% of the time with this product in nasal 
surgeries.[8]  The main reason for removal of this implant is the risk of infection which is 
about 4%.[13]  It has found success when used as a chin implant.  Gross et al. [27] used it 
for chin augmentations on 264 patients over a 14 year span.  It was found to have a 0.8% 
infection rate and 1.5% displacement rate. 
Proplast 
Proplast (polytetrafluorethylene) by Vitek is a firm and porous implant made from 
PTFE polymer and carbon fibers.  With pore sizes ranging from 100-500µm, the implant 
is surrounded and filled with fibrous tissue within a few months on implementation.  
Originally, the carbon fibers were black making it visible as an implant, especially for the 
nose, but Proplast II soon appeared which was made out of white aluminum oxide instead 
of carbon.  Its main advantages are that it is firm enough to provide support as well it is 
flexible and one of the easiest materials to shape.  It does, however, have a higher chance 
of extrusion when compared to other options like Mersilene.[11]  With it being highly 
porous (73%) and flexible, its primary limitation is its tendency to fragment and collapse 
under pressure and shear forces.[13]  It is most commonly used in malar augmentation 
with an implant removal rate of 7.6%.[10]  While it is still used abroad, the  United States 
Food and Drug Administration (FDA) withdrew its approval for the material in 1990.[14]  
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The fragmentation of the material was found to lead to progressive bone degeneration for 
the patient in as little as 1-2 years.[28] 
 
Dermal Fillers 
As people age, facial wrinkles and folds of the skin appear and become more 
prominent.  Dermal fillers are natural or synthetic injections into the mid to deep dermis 
of the face for correction of these wrinkles.  Recently they have started to be used to 
augment and contour small facial imperfections as well as fill in divots left by acne 
scars.[29] 
Market Size 
After Botox, a procedure which prevents the development of wrinkles by 
paralyzing facial muscles, soft tissue fillers are the second most common minimally 
invasive cosmetic procedure.  In 2013, the procedure was performed over 2.2 million 
times in the United States.  In addition, the use of soft tissue fillers is on the rise.  Its 
usage has increased 243% since 2000.[4]  Housman et al. found that it encompassed 
18.4% of all office based cosmetic visits.[30] 
Figure 2 was obtained from the FDA’s Executive Summary of Dermal Fillers.  
After reviewing 533 reports, the FDA found patient’s age’s ranged from 17 to 86 years 




Figure 2: Patient Age Range for Dermal Fillers 
Reference: [29] 
While dermal fillers have traditionally been used for the face, lately the market 
has expanded to include improving the look of crow’s feet, horizontal neck and chin 
folds, aging in hands, and nipple definition.  Although the FDA has not specifically 
approved fillers for these usage, doctors are allowed to use their own discretion for the 
benefit of the patient.[31] 
Regulatory Pathway 
The FDA approved the first wrinkle filler with the Zyderm Collagen Implant in 
1981.  Since then, another 20 have been approved with the most recent being in 2013[32].  
Their FDA product code is LMH and they are considered a Type 3 device.  Currently, 
they must be submitted through the premarket approval (PMA) pathway.[6] 
In 2008 the Executive Summary for Dermal Filler Devices was published by the 
FDA[29] to give a pathway for pre-market approval.  It includes the requirement of a 
randomized, controlled, multi-center clinical trial with a sample size around 150 patients.  
The assessment of patient’s wrinkle severity should be scored based on the Lemperle 
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Rating Scale (LRS) 3 and 6 months after injections through pictures by an independent 
reviewer.  In addition, the patients should receive follow up meetings at 3 and 14 days 
after injection as well as after 1, 3, 6, 9, and 12 months to determine if any adverse 
reaction had appeared.  
Another possible route to consider is through MIB (Elastomer, Silicone Block).  
The FDA defines this implant as an “ear, nose, and throat synthetic polymer material 
intended to be implanted for use as a space-occupying substance in the reconstructive 
surgery of the head and neck.”[6]  While not specifically used to minimize wrinkles and 
folds in the face, attempting to have the implant pass as just a facial space filler would 
reduce the time and money required for approval.  An argument could be made that since 
the implant would be a solid rod shape instead of microspheres within a gel, it does not 
belong within LMH.  MIB encompasses any space-occupying polymer within the face 
while LMH is specifically for dermal implants.  Products under MIB are considered to be 
Class II devices and require a 510K instead of a PMA.  Predicate devices under this code 
include silicone carving blocks for facial implants and gluteal, calf, and pectoral 
implants. 
Current Materials 
Materials for dermal fillers range from biologic to synthetic and absorbable to 
nonabsorbable.  They are considered short lasting if their affects are not evident after 6 






Hyaluronic acid ((C14H21NO11)n) is a naturally occurring glycosaminoglycan in 
the extracellular matrix.  Because the acid’s half life in the body is 1-2 days, all 
injectables have been chemically crosslinked with various chemicals to increase the 
lifetime of the product.[29]  These dermal fillers have become the material of choice.  In 
2013, 75% of all dermal fillers administered were from the four approved brand names: 
Hylaform, Restylane, Juvederm, and Elevess.[4]  Duration of the injection ranges from 
label to label.  Restylane’s and Perlane’s effects last up to 6 months while Juvéderm lasts 
from 9-12 months.  Site of injection also determines its duration within the body.  It lasts 
longer in areas of less muscle movement such as under the eyes as opposed to high usage 
muscle areas like the lips.[34] 
These injections have been proven safe for patients many times over.[34, 35]  
Nicholas et al. [36] injected these fillers into over 700 patients from 1996-2000.  Only 3 
patients (0.42%) had complications which was skin reactions 8 weeks after injection due 
to allergies and took 6 to 24 weeks to resolve.   
Collagen 
Collagen was the first type of dermal filler approved with Zyderm in 1981.  While 
it is composed of bovine collagen, Evolence is composed of porcine collagen, and 
Cosmoderm is made up of human collagen.[29]  Until the early 2000s, collagen based 
dermal fillers were the only option available.  Since 2000, however, their usage has 
decreased 90% while the overall usage of dermal fillers has increased 243%.[4]  
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Hypersensitivity reactions occur in 1-3% of patients using collagen.  In addition, 
since they are derived from a different species, there is a greater chance of eliciting an 
immune response.[37] 
Hydroxylapatite 
Hydroxyapatite is a biocompatible substance that has been used in implants for 
over 20 years.  Radiesse is synthetic biodegradable hydroxylapatite (particle diameter 25-
45 µm) suspended in carboxymethylcellulose.  It is approved for both the correction of 
facial folds and the signs of lipoatrophy in HIV patients.  It was injected into 285,000 
patients in 2013.[29]  The gel is absorbed and replaced with soft tissue within a few 
weeks.  HA exhibits little, if any, foreign body response and is highly biocompatible.[33] 
The longevity of Raduesse depends on many factors including age and 
metabolism.  Silvers et al found that 91% of patients still showed improvement at the end 
of an 18 month trial and there was a 97% satisfaction rate.[38]  With a population of 102 
patients, Bass et al claimed 40% still showed slight improvement at 2.5 years, however it 
was not nearly as prominent as it was at 6 months.[39]  Jansen et al found that 12.4% of 
patients developed nodules, but they were easily treated with steroids.  Patient 
satisfaction rate in that study was 89%.[40] 
Poly(methyl methacrylate)  
Poly(methyl methacrylate) (PMMA) microspheres, known on the market as 
ArteFill, was approved by the FDA in 2006.[29]  It consists of non-resorbable PMMA 
microspheres (30-50 µm in diameter) suspended in a bovine collagen and saline mixture.  
This is the only long lasting injection on the market currently.  Patients have the same 
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wrinkle improvement at six months as they did after one year as well as results have been 
shown to last up to 15 years.[31]  In 2013, it was used in 17,000 instances which was a 
decrease of 6% from the year before.[4] 
Its smooth surface and uniform size leads to minimum foreign body reaction.  Its 
potential complications include redness, itching, intradermal nodules, and hypertrophic 
scaring.  These usually arise from improper injection technique and are typically treated 
with steroids or extraction if the issues persists.  For three days after injection the spheres 
sit in a viscous paste before encapsulation, and muscle movement can push the 
microspheres deeper or closer to the surface of the skin.  Figure 3 shows intradermal 
nodules that were removed from a patient.[41]  In addition, wrinkles may appear 5-10 
years after injection from muscle movement shifting the spheres.[31] 
 
Figure 3: Intradermal Nodes Formed from Injected PMMA Microspheres 
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Characteristics for Facial Implants 
After reviewing facial implants, multiple issues became apparent with the current 
material options available for patients.  Characteristics of a facial implant need to be 
determined and quantified in order to help identify and create potential alternative 
materials.  The values of these characteristics are derived from those of the surrounding 
tissues (cartilage for nasal and chin implants and adipose tissue for dermal fillers) as well 
as thresholds given by the FDA through the standard ASTM F881.[42] 
Elasticity 
The main issue that arose with the most prominent market materials (silicone, 
Medpor, and Gore-Tex) is the unnatural feeling of the implants.  This is due to their 
rigidity being greater than the surrounding tissues.  An implant should have a similar 
firmness to the tissue it was trying to mimic or replace.  This characteristic is quantified 
as the elastic modulus or Young's modulus and its value ranges depending on the tissue 
type.   
Due to the change in elasticity between tissue types, values were found for both 
cartilage and adipose tissue.  The Young's modulus of cartilage is depth dependent.  Most 
of facial cartilage falls within the range of [0.3,1.3]MPa, however the deepest 20% could 
increase as high as 2.3MPa.[43]  Due to the nature of adipose tissue, determining it 
mechanical characteristics has been a difficult task.  The only mechanical characteristic 
of fat found in literature was its Young's modulus.  Krouskop et al.[44] found the 
modulus to range between 0.018 and 0.024MPa and Sarvazyan et al.[45] found a greater 




Tensile strength is the maximum stress a material can withstand while being 
stretched before breaking.  ASTM F881 states that the material for facial implants must 
have a minimum tensile strength of 1.38MPa.  The yield tensile strength for nasal 
cartilage was found by Richmon, et al. to be 1.95MPa ±0.24, or a range of 
[1.71,2.19]MPa.[46]  Thus, even if the material meets the FDA requirement, it still may 
not be strong enough to handle the everyday forces experienced by the face.  A minimum 
tensile strength of 1.71MPa, the lower end of its standard deviation, was chosen as the 
value's standard in this research in order to better mimic the characteristics of 
surrounding tissue. 
Elongation 
When choosing a material for an implantable device, an important characteristic is 
that the implant can stretch as much as its surrounding biological tissues.   ASTM F881 
states that implantable silicone should have a length increase of at least 200%.  Even if 
the material does not achieve 200% elongation, an argument should be made that it does 
not have to reach this benchmark, just that it can stretch as much as its surrounding tissue.  
Human cartilage has a linear stress/strain behavior up to 15% strain.[47]  After that, 
cartilage deformation ensues to at least 30% elongation.[48]  Thus, a minimum threshold 
of 30% would be a suitable elongation percentage of a facial implant due to the fact that 






Tear strength is the measure of a material's resistance to tearing.  A desired value 
for tear strength is not mentioned for silicone facial implants in ASTM F881.[42]  It only 
states that it must be determined and recorded.  Tear strength for cartilage is 
2.2kN/m.[48]  An implant should at minimum have the same tear strength as cartilage if 
not higher to prevent it from becoming damaged when experiencing everyday stresses 
within the face.  For this reason, a minimum tear strength of 2.2kN/m should be required 
for facial implants. 
Pore Characteristics 
The lack of porosity in some current materials like silicone gives rise to a higher 
migration and ejection rate than its porous competitors.  In order to help integrate an 
implant into the surrounding tissue and prevent unwanted movement, pore characteristics 
such as pore size and porosity should be considered. 
The required pore size for implants is dependent on the kind of desired biological 
ingrowth.  Fibrous ingrowth can be seen in pores with diameters between 5 and 15µm 
while bone regeneration typically requires pore diameters ranging from 100 to 400µm but 
can be as high as 700µm.[49-51]  While a microporous structure (under 50µm) does 
show some cellular attachment from the fibrous ingrowth, the strength of the bond is 
much less than one attached by bone ingrowth and the implant can more easily be 
dislodged.  This means that the implant can be more easily removed in the case of 
reconstruction; however it more likely to be shifted when placed under stress.  In 
28 
 
addition, the pore size is too low for macrophages to enter and can increase the risk of 
infection.  
The higher the porosity percentage of a material, the more structural linkage of 
the ingrowth material appears within the implant to ensure attachment and prevent 
slippage.  There is a wide range of porosity values within current biomedical materials, 
but Bruchman, et al. states that an implant should strive to have a minimum porosity of 
30%  to help this bonding.[52]   
Swelling 
Hydrogels have the ability to absorb water and swell in size.  While finding a 
swelling percentage is not required by the FDA, it is a useful property to know when 
using hydrogels for implants and can be used as an advantage in the design.  When 
administering an implant, the incision should be as small as possible to reduce noticeably 
and pain.  A smaller implant that grows within the body would reduce the incision.  One 
particular example is with dermal fillers.  If the PVA cryogel is smaller in size during 
injection and slowly swells within the body, this would allow doctors to use smaller 
diameter needles and cause less pain to the patient.[53]  In this case, the larger the 
volume increase of the PVA cryogel when placed in an aqueous environment, the more 
preferred it would be.  A minimum volume increase of at least 50% was considered large 




Summary of Acceptance Criteria for Facial Implants 
 
A summary of the range of acceptable values for facial implant characteristics is 
shown in Table 4. 





Adipose Tissue Young's Modulus (MPa) [0.005,0.05] [44, 45] 
Cartilage 
Young's Modulus (MPa) [0.3,2.3] [43] 
Tensile Strength (Mpa) ≥1.71 [46] 
Elongation (%) ≥30 [47, 48] 
Tear Strength (kN/m) ≥2.0 [48] 
Fibrous Pore Size (µm) [10,30] [49-51] 
Bone Pore Size (µm) [100,700] [49-51] 
Cellular 
Ingrowth 
Porosity (%) [30,90] [49-51] 
Volume 
Growth 




Poly(Vinyl) Alcohol Cryogel 
Hydrogels are swollen networks of a hydrophilic polymer and water via physical 
or chemical crosslinking.  They exhibit the ability to swell in water and retain a 
significant fraction of water in its interior structure without dissolving. The 
appropriateness of poly(vinyl alcohol) (PVA) cryogel hydrogels for various biomedical 
applications has been recognized because of their excellent biocompatibility, high water 
content, and chemical stability.  It has been examined for use as intervertebral disk nuclei 
[54], artificial articular cartilage[55], and as a contact lens material [1].  PVA hydrogels 
have been investigated extensively for articular cartilage applications due to their ability 
to mimic human tissue [1, 2, 54, 55].  PVA cryogel can be made with a wide range of 
physical properties to create soft materials made up of 10% wt PVA.  Very stiff 
hydrogels can be made with PVA weight percentage ranges up to 60%.[56]   
PVA is soluble in water but it must be crosslinked to form a hydrogel.  
Crosslinking can be performed through either chemical or physical methods.  Chemical 
techniques include chemical crosslinkers like glutaraldegyde and radiation.  A physical 
crosslinking method of  PVA cryogel is to cook with water in an autoclave to create an 
aqueous solution then thermally crosslink it using the freeze/thaw cycling method.[56, 
57]  This involves freezing the PVA cryogel in a chilled environment of at least -20°C 
then bringing it back to room temperature.  Both the number of freeze/thaw cycles and 
the duration of the freezing time influence the mechanical properties of the PVA 
cryogel.[54]  PVA cryogels formed through freeze–thaw cycling offer the additional 
advantage of being biocompatible as no toxic cross-linkers are required for physical 
cross-linking to occur.[57] 
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While PVA cryogel is desirable due to its range of properties that include 
biocompatibility, elastic softness that can mimic both fat and cartilage, elastic strength, 
durability within the body, manufacture-able at low cost, and FDA cleared for some 
medical areas, a main drawback is its lack of adhesion within the body.  Due to the lack 
of pores within PVA cryogel, there may be no attachment of the implant to the 
surrounding tissues.  Using porosity inducing methods, PVA cryogel should be 




Current Methods for Manufacturing Porosity in Polymers 
Cellular ingrowth is imperative in facial implants to help prevent movement and 
detachment.  This is achieved through either creating a porous material or texturing the 
surface.  The field of tissue engineering has been attempting to create porous materials 
for cellular scaffolds for decades.  Scaffolds for cells should have highly interconnected 
open pore networks for cellular ingrowth and nutrition diffusion, highly biocompatible, 
mechanical properties similar to the surrounding implantation area, and large and suitable 
surfaces for cellular attachment and growth.[58, 59]  Hydrogels (crosslinked 
macromolecular networks formed from hydrophilic polymers immersed with water) are 
typically used when creating scaffolds because of their biocompatibility, similarities with 
human tissue, and good cellular interaction capabilities.[49, 57] 
Solvent Casting/Particulate Leaching 
One method of creating pores is through particulate leaching. During this process, 
the hydrogel is cast over a porogen and solidifies.  The material is then placed in a 
solvent of the porogen in order for the porogen to slowly diffuse out of the hydrogel.[49, 
59]  After the porogen is dissolved, an open void is left as a porous matrix within the 
hydrogel.  The porogen most often used is sodium chloride because of its low cost, ease 
of use, and high availability.  Other common materials used are paraffin wax, sugar, and 
gelatin.[60]  With this method, porosity can be controlled by the amount of the particle 
added, while the size of particle dictates the size of the pores.  Even the shape dictates the 
structure with circular porogens creating a more interconnected matrix than cubic 
ones.[49]  Another method to increase interconnectivity is to heat the porogens to where 
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they ‘sweat’ and start to combine together.  This has been proven effective with salt and 
paraffin wax.[61-63]  The areas of the porogens that combine together to create open 
pores after the particles are removed. 
The salt leaching method has been tested extensively with many cell types and 
has shown no adverse effects on new tissue formation.[64-66]  This method does 
however require the use of organic solvents and the leaching component increases 
manufacturing time at a rate dependent on the thickness of the molded shape.[59]  In 
addition, some leaching methods include cytotoxic solvents, such as xylene for paraffin 
wax as well as there is the chance that not all of the porogen dissolves.[49, 67] 
Gas Foaming 
Conventional gas foaming techniques are commonly used to create porous 
materials.  In this method, N2 or Co2 are generated via a chemical reaction typically 
involving sodium bicarbonate or ammonium bicarbonate.  The inert gas is formed from a 
reaction and is dispersed throughout the polymer to create the pores.[49, 68, 69]  A 
surfactant is typically used to stabilize the foam while the polymer hardens to preserve 
these pores.  The microstructure created from this process is dependent on the foaming 
agent concentration, surfactant type and concentration, and the length of time of the 
solidification process of the polymer. 
Keskar et al. [69] used the chemical reaction of citric acid and sodium bicarbonate 
to create foam within a 15% wt polyethylene glycol diacrylate (PEGDA) solution.  
Interconnected pores with diameters ranging from 100-600µm were formed from the 
resulting CO2 from the reaction.  Cells then were seeded on the porous scaffold and 
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cellular ingrowth was seen in the pores after 2 weeks.  In addition, this method does not 
require a solvent and a dissolving period.[49, 70] 
Another gas foaming method is supercritical CO2–water emulsion templating.  
This involves forming a high internal phase emulsion made up of a polymer and CO2 at a 
high pressure (120-150 bar) in a reaction chamber.  After the polymer has solidified from 
chemical crosslinking, the pressure is released and the CO2 evaporates to leave behind 
the highly porous material.[49]   Surfactants are typically added to maintain the CO2 
within the polymer during the solidification stage.[71]  This method leaves no residues in 
the polymer matrix and the product does not require any other purification steps. [72]  It 
leads to a well-defined closed cell porous structure[73] and the use of CO2 is beneficial 
due to its inexpensive and non-toxic nature.[71]   
Porosity percentage is dependent on the value of the CO2 pressure as well as the 
viscosity of the polymer.  The higher the concentration of the polymer, the smaller the 
pore size.[72]  The expected pore size from the gas chamber method ranges from 2-
100µm.[74]  Cooper et al. [72, 73] performed this technique with low molecular weight 
10% PVA hydrogel and the average pore size ranged from 8-15µm. 
Composites 
Another method used extensively in tissue engineering involves creating a 
composite hydrogel by combining PVA cryogel with another material.  This other 
material could be either biodegradable or not, but it should encourage fibrinogen and 
bone growth to help for cellular attachment.    Some examples include titanium fiber 
mesh[75] and poly(vinyl pyrrolidone)[76].  While composites made with nonabsorbable 
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materials are used to enhance the mechanical properties of PVA cryogel, mixing with 
biodegradable materials may provide a porous matrix for cellular ingrowth as the material 
is absorbed by the body.[77]  Two notable examples are hydroxyapatite and chitosan.[70, 
77-80]   
Hydroxyapatite (HA) (Ca10(PO4)5(OH)2) is a major inorganic component (about 
60% wt) of bone and teeth.[67]  Because of its ability to encourage bone attachment, 
differentiation, and proliferation, it is used to coat implants such as hip replacements and 
dental implants as well as implanted on its own.[81]  Its absorption rate in the body is 
slow and can take months or even years.[67]  PVA cryogel/HA composites in in vivo 
studies have been proven to be biocompatible and they encourage osteoid tissue growth 
(the precursor to bone tissue) within two weeks of implantation.[70, 77]  The HA 
particles within the composites ranged from 0.07-5µm.[81] 
Chitosan (CS) ((C6H11NO4)n) is a polysaccharide derived from chitin.  It is an 
extremely favorable material in the biomedical field because of its biocompatibility, 
biodegradability, and bioactivity, however its brittle nature has limited its usage.[78, 82]  
The biological effects of PVA cryogel/CS composites have been studied both in vitro and 
in vivo.  Nontoxicity has been proven and cellular proliferation is seen within 2 
weeks.[80, 82]  In a 3 month in vivo rabbit implantation study, bone cells had grown and 
proliferated throughout the small implanted composite within the cartilage. 
Creating a composite material of PVA cryogel with HA or CS could encourage 
cellular growth into the implant as well as slowly give a porous matrix for ingrowth as 





Implants for facial augmentation provide a structural framework, minimize 
defects, and bring the area to an pleasing anesthetic look.  A facial implant's material 
must be biocompatible, easily shapeable, prevent migration, and possess similar 
mechanical properties to the surrounding tissue.  Current materials on the market, 
however, have many issues associated with them.  Cartilage replacements have a range of 
problems that include displacement and ejection to an unnatural feel within the body.  
Most dermal fillers are only temporary while those that are permanent can lead to 
disfigurement if they become infected or rejected.  Poly(vinyl) alcohol cyrogel is a 
permanent biocompatible hydrogel that can be made in a range of mechanical properties 
similar to tissues within the body.  A potential drawback is its lack of fibrous attachment.  
Adhesion may be achieved with the incorporation of pores through pore forming 
techniques and changing the surface texture.  Further, an implant that could be inserted 
through a small incision that swells in situ would have insertion advantages.  In this 
thesis, porous PVA cryogel was created and its mechanical, pore, and swelling 





MATERIALS AND METHODS 
Experimental Design 
Due to issues of current biomaterials, poly(vinyl) alcohol cryogel has arisen as a 
promising replacement for facial implants.  Its many positive traits include its 
biocompatibility, ability to be manufactured with a range of mechanical properties similar 
to biological tissues, and resistance to degradation within the body.  The implant may be 
subject to movement and migration.  Pores may encourage adhesion. Porosity inducing 
techniques were applied to PVA cryogel to help combat this issue. 
A range of experiments were designed to manufacture porous PVA cryogel and to 
determine its mechanical and porous characteristics.  These properties include elasticity, 
tensile strength, elongation percentage, tear strength, pore size, and porosity percentage.  
The mechanical tests were performed on the samples in tension and are adapted from the 
standards ASTM D412[83] and ASTM D624[84].  The pore characteristics were 
determined from sectioned sample images and analyzed through programs such as 
Matlab and Image J.  To determine PVA cryogel's ability of swelling, nonporous PVA 
cryogel was dried then placed in water to measuring the increase in size.  Molds were 




General Method of Manufacturing Poly(Vinyl) Alcohol 
Poly(vinyl alcohol) (PVA cryogel) is made by dissolving its granular form in 
water, pouring the solution into a mold, then putting it through multiple freezing and 
thawing cycles.  The hydrogel forms to the exact shape of the mold. 
Granular PVA was obtained from Sigma (Milwaukee, WI) (catalog number 
363065) with an average molecular weight of 124,000-186,000 and 99+% hydrolyzed.  It 
is mixed with deionized water, the container is capped, and it is cooked in the autoclave 
at 255°C for 30 minutes to dissolve the PVA in water.  For a 10% weight solution of 
PVA cryogel, 11.111g of PVA is used for every 100mL of deionized water.  To obtain 
30% weight PVA cryogel, 42.853g of PVA is used for every 100mL of deionized water. 
Once removed from the autoclave, the viscous PVA cryogel solution is poured 
into a mold of the desired shape of the PVA cryogel.  This can be done by either pouring 
the PVA cryogel directly into the mold or when constricted with smaller insertion areas, 
poured into a 20mL syringe then injected into the mold.  The injection method can be 
used for a solution up to 25% weight PVA cryogel.  Greater weight percentages are too 
viscous to easily press through.  Multiple shaped molds were used for prototyping and 
mechanical testing.  These include molds to create chin and nose shapes, extruded 
cylinders, and shapes required for mechanical testing. 
The hydrogel becomes solid by thermal crosslinking through a freeze/thaw cycle 
process.  Once secured within the mold, PVA cryogel is placed within a freezer of at least 
-20°C to begin the freezing process.  When the specimen is frozen (about 4 hours), it 
turns from clear to white in color.  The mold is then removed from the freezer and placed 
at room temperature to begin the thawing process.  When the specimen warms up to room 
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temperature (2 hours), a full freeze/thaw cycle has been completed and it is placed back 
into the freezer to begin the next cycle.  All specimens underwent 6 freeze/thaw cycles 
during the course of this project.   
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Manufacturing the Molds 
Chin and Nose 
Shapes for the chin and nasal implant were designed using SolidWorks® V2013 
CAD software (Dassault Systèmes Solidworks Corporation, Waltham, MA).  To obtain 




Figure 4: Images and Dimensions of Silicone Facial Implants 
Reference: Spectrum Design Medical [85] 
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From these dimensions found online, nasal and chin implants were designed in 
Solidworks.  The nose is in the shape of an 'L' with dimensions 1.1cm width x 3.3cm 
length x 4.80cm height and shown in Figure 5.  The chin is in the shape of a half-moon 
with dimensions 1.40cm width x 3.98cm length x 0.65cm height.  Details of the designed 
chin and nasal implant can be seen in Figure 6. 
 




Figure 6: Design of the Chin Implant 
 
Molds were created from the CAD of the implants.  The two-part molds are held 
together with screws that run its length.  The parting lines follow the main edge of the 
implants.  This was done to minimize flash from the manufacturing process as well as 
make it easier to cut the implant away after it is removed from the mold.  During early 
prototyping stages, molds for these implants were created through additive manufacturing 
using the 3D printer Dimension (Stratasys, Eden Prairie, Minnesota).  While inexpensive 
and quick to produce, these molds gave a rough surface to the implants.  The layers of the 
mold were evident on the implant and gave it a rough appearance.  An example of these 
molds are shown in Figure 7.  When a final design was chosen, aluminum molds for the 
chin and nose were manufactured by the Georgia Tech Machine Shop.  The implants 




Figure 7: 3D Printed Molds for Chin and Nasal Implant 
 
 






The extruded cylinder implants are created using Tygon® tubing  (Saint-Gobain 
S.A, Paris) of a length of 25cm.  The 3mm diameter tubing is injected and filled with 
PVA cryogel pushed from a 10cc syringe.  To prevent the PVA cryogel from spilling out 
of the tubing, the tubes are orientated in a 'U' shape within a bowl with the edges of the 
tubing pointing upward.  This is shown in Figure 9.  After the completion of the first 
freeze/thaw cycle, the mold is removed from the bowl and straightened.  At this point the 
PVA cryogel has solidified enough that it will not run out of the mold, and straightening 
the tubes will help prevent the PVA cryogel from curving.  Once 6 freeze/thaw cycles are 
completed, the PVA cryogel is removed from the tubing by pressing down on one side of 
the tube and it slips out the other end.  The PVA cryogel 'noodle' can then be segmented 
with scissors to create whichever length of cylinder is required.  An image of the noodle 
implant is shown in Figure 10. 
 




Figure 10: Image of Extruded Cylinders 
Molds for Mechanical Testing Samples 
Two mold shapes were created for the purpose of mechanical testing.  Their shape 
and dimensions are in accordance with ASTM D412[83] and ASTM D624[84].  ASTM 
D412 calls for “dog bone” shaped molds to determine tensile strength, elongation, and 
elasticity.  ASTM D624 requires a “zig-zag” shape to complete tear strength tests. 
Acrylic sheets purchased from McMaster Carr (Atlanta, GA) were used to 
manufacture these molds.  Each mold was comprised of one 2mm thick sheet sandwiched 
between two 13mm thick sheets.  The shape of the samples was designed in SolidWorks 
(shown in Figure 11) then cut into the thin middle sheet using the Trotec Speedy 300 
laser cutter (Trotec, Wels, Austria).  The thin newly cut piece was then super glued using 
Professional Liquid Super Glue (Loctite; Düsseldorf, Germany) to one of the thicker 
sheets.  This gave a sunken mold that the PVA cryogel could easily be poured into.  The 
molds are pictured in Figure 12.  The other thick sheet of acrylic is used to cover the 
PVA cryogel after it has been poured into the mold.  Because this mold is flatter and 
wider than the chin and nasal molds, clamps are used instead of screws to secure the 
mold.  The parting line for this mold also runs along the edge of the shape which reduces 






Figure 11: Mechanical Testing Shapes 
Created in Solidworks A) dog bone shape from ASTM D412 B) zigzag shape from ASTM D624 
 
 
Figure 12: Acrylic Molds Used to Create Samples for Tensile Tests 
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Overview of Tests 
Tensile Strength, Elongation Percentage, and Elasticity 
Samples of PVA cryogel were tested in accordance with ASTM D412 [83] to 
determine tensile strength, elongation percentage, and elasticity.  This protocol published 
by the American Society for Testing and Materials is meant to evaluate the tensile 
properties of vulcanized thermoset rubbers and thermoplastic elastomers.  This standard 
is listed in ASTM F881 (Standard Specification for Silicone Elastomer Facial Implants) 
as a recommended test for silicone intended for facial implants.  ASTM F881 [42] is a 
standard noted by the FDA in the Guidance Documents for facial implants in product 
categories FWP, FZE, and MIB.[6] 
The PVA cryogel test strips were manufactured by using the ‘dog bone’ acrylic 
mold described earlier.  After the PVA cryogel was removed from the autoclave, it was 
poured into the slots of the mold and a 13mm thick sheet of acrylic was pressed down on 
top.  The sheets were then compressed between two large clamps and the mold 
underwent 6 freeze/thaw cycles.  After the PVA cryogel was removed from the mold, 
each ‘dog bone’ sample was examined and any with imperfections were discarded. 
The machine used for testing was the DDL 650 (Distribution Dynamics Labs, 
Minnesota).  It is equipped with software-driven computerized controls and automated 
data collection.  Wedged jaw clamps were used to hold the specimen in place.  The 
surface of the clamps was rough to prevent slippage of the PVA cryogel during the test.  
The ‘dog bone’ specimen was placed within the grips of the machine with care to make 
sure the specimen was aligned as straight as possible.  The clamps were spread 
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approximately 70mm before the start of the test with zero load applied.  The exact clamp 
distance as well as the specimen's thickness and width were noted, and the force and 
distance measurements were zeroed before the test began.   
The test was conducted by the upper clamp moving away from the lower clamp of 
a rate of grip separation of 500mm/min (20in/min).  Pictures of the process over time can 
be seen in Figure 13.  Using a sensor built into the machine, data were collected for the 
force (in pounds) and change in position (in inches).  Data collection began when the 
pulling force exceeded 0.1lb.  The specimen was stretched until rupture and the data were 
saved.   
 




Samples of PVA cryogel were tested in accordance with ASTM D624 [83] to 
determine tear strength.  This protocol published by the American Society for Testing and 
Materials is meant to evaluate the tear strength of conventional vulcanized thermoset 
rubbers and thermoplastic elastomers.  As with ASTM D412, this standard is listed in 
ASTM F881 as a requirement for facial silicone implants. 
The PVA cryogel test strips were manufactured by using the created ‘zig-zag’ 
shape acrylic mold.  Similar to the ‘dog bone’ samples, the PVA cryogel was removed 
from the autoclave, poured into the opening slots of the mold, and a 13mm thick sheet of 
acrylic was pressed down on top.  The sheets were then compressed between two large 
clamps and the mold underwent 6 freeze/thaw cycles.  After the PVA cryogel was 
removed from the mold, each specimen was examined and any with imperfections were 
discarded.  A scalpel was used to create a 1mm long nick in the middle of each specimen 
as described by the standard. 
The machine used for testing and the testing procedure was the same one used for 
the tensile testing.  The thickness of the specimen was noted, and the machine collected 
the force (in pounds) and change in position (in inches) when the pulling force exceeded 
0.1lb.  The test ended when the specimen split in half.  All specimens were monitored to 
make sure the tear fell along the line of the administered nick.  If not, then the sample 






The device used to section the specimens was the Leica CM3050 S Cryostat 
(Leica; Wetzlar, Germany).  It was found that the PVA cryogel sectioned most easily 
when frozen.  An attempt to section it was made on a microtome, however the PVA 
cryogel shriveled in the warm paraffin wax embedment and fell out of its wax casing 
during the sectioning process. The warm PVA cryogel also did not cut easily or cleanly. 
After the PVA cryogel had undergone its 6 freeze/thaw cycles and was removed 
from the mold, it was cut into a 0.5 cm cube.  This cube was placed inside a plastic 1.0 
cm cube container and the remainder of the cube was filled with Tissue-Tek O.C.T. 
Compound (Sakura Finetek; Torrance, California).  Embedding the PVA cryogel allowed 
it to be easily sectioned later.  To remove any excess bubbles and to ensure the OTC 
compound fully penetrated the pores of the PVA cryogel, the plastic container was placed 
inside a vacuum chamber and the air was removed until the pressure reached -25 atm..  
The specimen was left in the chamber until all bubbles had been removed from the OTC 
compound liquid.  This process took about 20 minutes.  Afterwards, the specimen was 
placed in a freezer at -20°C and remained there until both the OTC compound fluid and 
the PVA cryogel fully froze (about 30 minutes). 
The temperature of the sectioning area of the cryostat was set to -25°C.  Once the 
PVA cryogel and OTC compound had frozen and solidified, then were removed from the 
plastic container and attached to the sectioning pad.  Once this pad was attached to the 




The Nikon Eclipse E600 microscope (Nikon; Tokyo, Japan) was used to view and 
take pictures of the samples.  The images were taken at 4X magnification.   
Pore Size 
Public domain image processing program Image J® (National Institutes of 
Health; Bethesda, Maryland) was used to determine pore sizes within the porous PVA 
cryogel samples.  This was done through the Measuring Tool within the program.  Pores 
were identified as the empty void areas within the PVA cryogel with dark perimeters.  At 
least 20 pores were measured within each image to determine the pore size range.  An 
example of this process is shown in Figure 14.  Lines were drawn across the length of the 
pores and the diameter length was calculated as a ratio to the scale bar in the bottom right 
corner.  The mean pore size was also calculated through this program.  A example of the 
summary of the measurements is shown underneath the measurements in Figure 14. 
 





The porosity percentage of the manufactured porous PVA cryogel was also 
obtained using images of the sectioned samples.  Samples were sectioned at multiple 
depths as well as images were taken in multiple areas of each picture.  At least 5 samples 
were used for each type of porous PVA cryogel.  These images then were analyzed 
through Matlab® (Natick, Massachusetts).  A simplified version of the code is presented 
below.  To summarize, images were opened and converted into 2-tone black and white 
images.  The threshold was chosen to be high enough such that the grey PVA cryogel 
would be converted to black in the image while the white background (the open pore part 
of the sample) would remain white.  Each white pixel then was assigned a value of 1 
while each black pixel became 0.  Summing the pixel values of the image gave the 
number of white pixels within the image.  The size of the image was determined by 
multiplying its length and width together.  The number of white pixels over the total 
number of pixels in the image gave the percent of the image that was white or the percent 
porosity. 
I = imread('image.png'); % Opens the image 
BW = im2bw(I,.9999); % Creates black/white two tone image 
[x,y]=size(BW); % Calculates image pixel width and height 
total_pixles = x*y; % Calculates number of pixels in image 
white_pixles = sum(BW(:)); % Finds number of white pixels  
     % in image 
porosity = (white_pixles ./ total_pixles); % Finds  
     %percentage of white space in image 
 
This code was used for all images except those using CaPO4.  Unlike the others, 
the black part of these images is the porosity.  The Matlab code below shows that it was 
calculated by finding the difference of 1 and the white space.   
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porosity = 1 - (white_pixles ./ total_pixles); % Finds percentage 
           %of black space in image 
 
Swelling Ratio 
The swelling ratio test was performed on nonporous 10, 20, and 30% wt PVA 
cryogel.  Five samples were used for each group. 
After the specimen has completed its 6 freeze/thaw cycles, it was removed from 
the mold and placed in an open air space.  This was done to dry out the sample.  The 
specimen dehydrated over the next week.  To determine if all the water had be removed 
from the specimen, its weight was measured every two days.  When the specimen's 
weight did not change between weighings, it was deemed to no longer have any water in 
its composition.  The weight of the sample was noted.   
The sample was then placed in deionized water for a week to allow it to swell.  
Again, its weight was monitored until there was no change.  At this point the specimen 
was deemed to be fully swelled.  The weight was noted again.  From the weight and 
density, the volume of the specimen was calculated.  The calculated volume increase, or 
the swelling percent increase, is the change in volume from the dehydrated to saturated 
PVA cryogel.  It was calculated as 
                           
       
  
     
Where VS is the volume of the saturated PVA cryogel and VD is the volume of the 
dehydrated PVA cryogel. 
Density was calculated for each sample in both hydrated and dehydrated states. A 
large sample of each specific weight PVA cryogel (plain 10, 20, and 30%) was 
dehydrated in open air.  When all the water was removed, the specimen was weighed 
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then placed in a graduated cylinder filled with water.  The increase of the water level was 
taken as the volume of the specimen.  The weight of the specimen over the volume was 
determined to be the density.  Weight and volume were measured again after the 
specimen was saturated with water to determine the density at that state as well.  
Knowing the density of each sample type allowed for only the measurement of weight of 
each individual sample.  The volume of the sample was then calculated by dividing the 





Manufacturing Porous Poly(Vinyl) Alcohol Cryogel 
PVA cryogel was subjected to multiple porosity inducing techniques in the effort 
to make pores.  Samples that did not undergo these methods and remained completely 
solid are considered 'plain' PVA cryogel. 
Solvent Casting/Particulate Leaching 
The salt was prepared for this method by first shifting it through sieves to have a 
set range of pore diameter of 100-600µm.  The sieves were purchased from McMaster 
Carr (Atlanta, GA) and were certified by the manufacturer to meet all standards required 
by ASTM E11 (Standard Specification for Woven Wire Test Sieve Cloth and Test 
Sieves).  The width openings of the sieves were 100 and 600µm. 
Once selected according to size, the salt particles were poured in 100mL syringes 
and then subjected to 95% humidity at 50°C for 24 hours.  This method was adapted from 
Murphy et al. [61]  Salt crystals are cubic in shape and are not as effective as spherical 
shapes when trying to create an open pore structure.[49] An example of two salt crystals 
interacting together is shown in Part A of Figure 15.  The incubation of the salt in 
humidity for 24 hours causes the salt to ‘sweat’ and partially fuse together, as shown in 
Part B of Figure 15.  The salts bridge together to allow for an open cellular matrix as well 
as the edges of the crystals become more curved.  When the salt is removed after 24 
hours, it has become a connected skeletal-like structure to create a porous open cellular 
matrix. 
 
Figure 15: Salt Crystals 
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PVA cryogel from the autoclave is poured directly into the syringes that hold the 
cooked salt.  The plunger part of the syringe is then pressed down and the pressure 
created forces the PVA cryogel into the salt matrix.  Once the PVA cryogel had been 
forced as deep as possible (1cm for 10% wt PVA cryogel, 2mm for 20% wt PVA 
cryogel), the mixture was removed from the syringe and placed in the desired mold.  It 
then underwent the necessary 6 freeze/thaw cycles. 
The final step is to remove the porogens from the PVA cryogel to reveal the 
porous matrix.  The salt particles were leached out over time by placing the specimen in 
deionized water.  This solvent was refreshed every 4 hours until all the salt was removed.  
The time for this process is dependent on the size of the molded part and the depth of the 
porogen pressed within the PVA cryogel.  The salt was leached out of the samples for 
these experiments within 4-5 days.  The samples were felt by hand to determine if the salt 
had been removed.  This involved squeezing the sample and feeling for any hard granular 
substance within the softer porous PVA cryogel.   Once no more salt could be felt the 
sample was soaked for another 2 days.   
This technique was attempted with a wide range of concentrations of PVA 
cryogel, however it was determined that concentrations above 20% are too solidified to 
enter the salt matrix when the salt’s diameter is between 100 and 600µm.  A larger 
porogen diameter would leave larger gaps between particles and allow higher 
concentrations of PVA cryogel to be utilized. 
Paraffin wax was also attempted as a porogen.  While it is dissolvable in xylene 
and can be heat treated (between 35 and 45°C) to bridge the particles together to help 
create an interconnected matrix, wax easily melts and deforms when exposed to 
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temperatures over 58°C.  PVA cryogel would have to be cooled to below this temperature 
threshold after removal from the autoclave for use, and at temperatures this low PVA 
cryogel starts to harden and becomes almost impossible to press into the wax matrix.  Ma 
et al. [62] utilized paraffin wax to create porous PVA cryogel, however the PVA cryogel 
concentration used was only 0.5%.  While at this concentration the PVA cryogel solution 
can be cooled low enough to still be fluid, concentrations this low are not suitable for the 
implants currently under consideration which require a range of 10-30% weight PVA 
cryogel. 
Gas Forming Method 
Sodium bicarbonate (NaHCO3) (Sigma, St. Louis) was chosen as the foaming 
agent because of its low cost, accessibility, and biocompatibility.  It was combined with 
citric acid (C6H8O7) (Sigma, St. Louis) according to the methods described by Kabiri et 
al.[68]  The exothermic reaction of sodium bicarbonate and citric acid in the presence of 
water creates the products trisodium citrate (Na3C6H5O7), carbon dioxide, and water.  
This equation in shown in the equation below. 
                                               
Trisodium citrate is used as an anticoagulate in the medical field and is a common 
food preservative. 
This method begins right after PVA cryogel is removed from the autoclave.  20% 
wt PVA cryogel (25g PVA cryogel, 100mL of deionized water) was used in all data 
collecting experiments.  10, 20, and 30% wt PVA cryogel were originally tested with this 
method.  It was observed that 10% wt PVA cryogel did not contain enough PVA cryogel 
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to maintain the porous structure through the first freezing process while 30% did not 
contain enough free water to fully activate the chemical reaction.   The PVA cryogel is 
poured into a 1L beaker that holds a mixture of 6.0g sodium bicarbonate and 4.574g citric 
acid.  The chemical reaction begins as soon as the PVA cryogel solution touches the 
chemical mixture.  The solution was stirred vigorously for 1 minute with a stirring 
utensil.  From this, a frothy white column of foam forms within the beaker.  The volume 
of the foam fills up two thirds of the 1L beaker.  
While some of the gas foaming procedures in the literature used surfactants to 
help stabilize and maintain the porous matrix, it was decided that surfactants would not 
be used in this experiment.  Liquid Dove soap (Unilever; Rotterdam, Netherlands) was 
tested as a surfactant for this procedure because it is inexpensive, widely available, and is 
composed of surfactants sodium lauroyl isethionate, lauryl alcohol, tallow acid and 
palmitic acid. Dove soap, however, was determined to have no effect on maintaining the 
porous matrix and left the PVA cryogel sticky and soapy.  Freezing time was determined 
as a factor in keeping the pores intact. The sooner the PVA cryogel was frozen, the less 
bubbles popped and CO2 escaped from the foam.  For the conventional gas method then, 
the PVA cryogel’s first freeze was at -80°C instead of -20°C to quicken the freezing 
process.  The molds were also prefrozen to help chill the PVA cryogel mixture as fast as 
possible. 
Dry ice was used as the freezing agent to create an environment of -80°C.  It was 
placed into a thermally insulated cooler along with the intended mold.  Once the PVA 
cryogel was mixed and the column of foam appeared in the beaker, the foam was 
removed, spooned into the mold, and quickly placed with the dry ice.  After an initial 
59 
 
freezing time of 1 hour, the mold was removed and thawed to room temperature.  This 
marked the end of the first freeze/thaw cycle.  The remaining 5 freeze/thaw cycles were 
performed as usual.   
It should be noted that conventional gas formation was the only gas forming 
method attempted.  C/W emulsion was considered, but the lab lacked the required 
laboratory equipment such as a high pressure reaction vessel.  This made performing this 
type of test unfeasible.  When looking at the literature, no studies were found that used 
this method that produced pores larger than 15µm.[71, 74]  In addition, this method 
creates closed cell hydrogels which do not allow cellular ingrowth and adhesion.[86] 
PVA Cryogel Composites 
Methods to create composite materials of PVA cryogel and biodegradable 
polymers were also examined.  Because of the plethora of literature available, chitosan 
(CS) and hydroxyapatite (HA) were chosen for experimentation.  HA, however, is 
difficult to find and a very expensive compound.  Manufacturing it proved to be a 
difficult and costly task.  It was decided to replace HA with a similar compound for these 
experiments: calcium phosphate (CaPO4). 
Multiple methods to combine chitosan with PVA cryogel were given in the 
literature including chemical crosslinking[80] and cooking together at low 
temperatures.[82]  Chemical crosslinking introduces extra, sometimes toxic chemicals 
into the implant as well as reduces the rate of absorption of the CS.  While PVA cryogel 
at lower molecular weights can be cooked at temperatures 80°C and under, the PVA 
cryogel used in these experiments required a high temperature and pressure to dissolve in 
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the water.  CS percentages of 2.0% and 4.0% were chosen to be added to the PVA 
cryogel mixture.  This weight percent is similar to that used in the literature[78, 80, 87] as 
well as it felt to have a similar strength to plain 30% PVA cryogel in comparison to other 
CS weight percents.  At 5% and greater the composite started to become brittle.  2.0g and 
4.0g of CS were each combined with 42.583g PVA cryogel and 100mL of water in the 
autoclave at 255°C for 30 minutes.  They were placed into molds and underwent 6 
freeze/thaw cycles like normal.   
Like CS, calcium phosphate also was mixed with PVA cryogel and cooked in the 
autoclave.  Mixtures of 5.0g and 10.0g CaPO4 were used with 100mL of saline and 30% 
weight PVA cryogel.  Additions of 5% and 10% CaPO4 were chosen because these 
values are equivalent to what is seen in the literature for HA[77]. 
While these materials would be implanted as composites, the CS and CaPO4 
molecules need to be leached out of the PVA cryogel to determine the pore size and 
porosity the material will have after the body absorbs the CS and CaPO4 and leaves an 
open matrix.  
Molded Surface  
Another method to create porous PVA cryogel is to have the mold designed to 
create the pores.  This method requires no extra chemicals or steps.  The surface of the 
mold is textured in a way that will reflect in the surface of the mold; ideally to encourage 
cellular ingrowth.  This can be done by having extrusions on the surface of the mold.  
The PVA cryogel will form around these extrusions which will lead to void space in the 
implant's area after the mold is removed.  This idea is especially appealing when the 
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implant would only require a slight attachment on the surface to prevent slippage and 
migration. 
A few types of surface textures were considered such as extruded cylinders and 
domes, but the one selected for testing is similar in shape to a light bulb.  An image of the  
proposed structure is shown in Figure 16.  This shape is appealing because it increases in 
area as it is farther from the surface of the mold which will lead the area of the holes in 
the implant it increase with its depth from the surface.  The cells can expand in this area 
which can allow better anchorage of the implant to the surrounding tissue.  
 
Figure 16: Image of Proposed Light Bulb Shape 
A chin mold was designed and attempted to be 3D printed with this surface area, 
however the details were too fine.  With extrusions of diameters 300-500µm and heights 
1mm, the 3D printer's tolerance levels were too large.  The extrusions formed together 
into one mass.  It was then realized that this shape is equivalent to that found on Velcro.  
The idea was conceived by lab mate Max Nguemeni.  3M Dual Lock brand Velcro (3M, 
Minnesota) was used in all experiments.  An image of the Velcro used is pictured in 
Figure 17.  The Velcro was glued to some of the manufactured molds, such as the chin 
mold, to be used in experiments.  The Velcro was used on only one side of the molds, 
including the samples used for the mechanical testing.  During manufacturing, the PVA 
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cryogel was just pressed into the Velcro surfaced mold and underwent the 6 freeze/thaw 
cycles like normal.   
 
Figure 17: Velcro Used to Mold Pores in PVA cryogel 
Removing Material 
The final method that was undertaken was to remove sections of the PVA cryogel 
after it had undergone its freeze/thaw cycles.  Like the method using Velcro for the 
mold’s surface, this requires no extra chemicals, porogens, and solvents.  It does, 
however, require the extra step of removing the PVA cryogel after it has solidified. 
The method used to remove the PVA cryogel is to press a stainless steel needle 
through the PVA cryogel.  An example is shown in Figure 18.  The needle used in all 
experiments was 10cm in length and had a diameter of 0.6mm.  Once pressed through, 
the needle leaves an extruded hole within the implant that the cell can grow into.  While 
this method was performed by hand in these experiments, it could be easily automated.  











The test materials were measured for mechanical properties, porosity and 
swelling.  Certain combinations provided appropriate mechanical, porosity, and swelling 
for use as facial implants.   
Images of Porous PVA Cryogel Samples 
The PVA cryogel samples were molded in the chin molds and are presented in the 
figures below.  
 
Figure 19: Plain PVA cryogel 
A) 10% wt PVA cryogel B) 20% wt PVA cryogel C) 30% wt PVA cryogel
 






Figure 21: 30% wt PVA Molded over Velcro 
 
 
Figure 22: Porous PVA Cryogel Created through Solvent Casting/Particulate Leaching Method 
A) 10% wt PVA cryogel B) 20% wt PVA cryogel  
 
 
Figure 23: Porous PVA Cryogel Created through Gas Method with 20% wt PVA cryogel 
 
Figure 24: PVA/Chitosan Composite 






Figure 25: PVA/CaPO4 Composite 






Tensile Strength, Elongation, and Elasticity 
Samples of 10%, 20%, and 30% wt PVA cryogel and all porous PVA cryogel 
samples were tested in tension (n>=3).  A representative force elongation curve for a 30% 
PVA cryogel material is shown in Figure 26. 
 
Figure 26: Force vs.  Deformation in Tension Test 
Data used are from Sample 4 of 30% wt PVA cryogel 
Mechanical values were determined using the process given in ASTM D412.  
Tensile stress (MPa) at a specific increase (xxx) in elongation is defined as:  
       
      
 
 
Where F(xxx) (N) is the force measured at a specific elongation and A is the cross-
sectional area (mm
2
) of the unstrained specimen.  This means that engineering stress was 
determined, not true stress.  The tensile strength (MPa) is then: 
   





The maximum force recorded is the magnitude of the force at the specimen’s 
yield point. 
Elongation (percent increase of the original length) is calculated as: 
      
        
    
 
L (meters) is the observed distance between the machine’s clamps on the 
extended specimen and L(0) (meters) is the original distance between the clamps.  The 
ultimate elongation is the L at F(max) and specimen rupture.  
A tensile strength vs elongation graph is presented in Figure 27.  The specimen 
shows a linear elastic elongation for the first quarter of the test then around 50% 
elongation exhibits a change in slope.  This signifies that the specimen has entered plastic 
deformation.  From the slope of the first linear part of the data, the modulus of elasticity 
(E) can be determined.   
   
   
  
 
The modulus of elasticity is the change in stress over the change in strain, i.e., the 
slope of the early part of the graph in Figure 27.  It was calculated in Microsoft Excel® 
using the SLOPE function over the beginning portions of the data before the slope 
change.  Each sample was examined to determine where this slope change took place to 




Figure 27: Tensile Strength vs. Elongation in Tension 
Data used are from Sample 4 of 30% wt PVA cryogel. Portion used to determine elasticity 
highlighted in red.  Treadline of slope shown as dotted black line. 
 
The stress/strain graph presented in Figure 27 is that of a nonporous 30% wt PVA 
cryogel sample.  The graphs created from porous PVA cryogel samples had much more 
fluctuating data, most likely due to the fact porous materials are not completely solid but 
filled with void space.  The elasticity was still determined as the slope of the beginning 
portion of the data.   Examples of this are presented in Figure 28.  A stress/strain graph of 




Figure 28: Tensile Strength vs. Elongation in Tension for Porous PVA cryogel 
Data used are from Sample 1 of 20% wt porous PVA cryogel created with salt method 
 
The data collected from all tests performed in tension with the calculated yield 
tensile strength, percent elongation at break, and modulus of elasticity are presented in 
Table 6.  Visual comparisons in bar graph form for these mechanical properties are 
shown in Figure 29, Figure 30, and Figure 31 respectively. 
Due to small sample sizes (<30 samples), a t-test (1 way, unequal variance) was 
performed in Microsoft Excel® on multiple pairings of the types of porous PVA cryogel 
to determine statistical difference between them.  A p-value less than 0.05 was 
considered statistically significant.  These pairing compared the mechanical values of 
porous PVA cryogel to its plain weight percent counterpart as well as the other porous 
sample created through the same method with a different PVA cryogel weight percent.  





The Young's Modulus was calculated as the slope created from the beginning 
portion of the stress/strain curve found from the samples.  Tensile strength (MPa) over 
elongation (unitless) gives the modulus a unit of MPa, or N/mm
2
.  The modulus for each 
type of PVA cryogel is listed in Table 8, a graph for comparison is shown in Figure 32, 
and a statistical comparison is listed in Table 9. 
A distinct difference can be seen in the elastic modulus between the plain PVA 
cryogels tested.  10% wt PVA cryogel has a modulus of 0.08MPa, 20% wt PVA cryogel 
is three times greater at 0.20MPa, and 30% wt PVA cryogel is five times greater with an 
average of 1.20MPa. 
Poked 30% wt PVA cryogel has an elastic modulus of 1.24MPa which is similar 
to that of plain PVA cryogel.  With a P-value of 0.24, they are not statically different.  
The molded PVA cryogel did show a 27% reduction though with a modulus of .8MPa. 
The gas method produces the smallest modulus of 0.04MPa.  This is six times less 
than the plain 20%. 
In regards to the PVA cryogel cast over salt, both showed the elastic modulus 
reduced 25%.  10% salt became 0.06MPa while 20% salt became 0.18MPa. 
A trend can be seen in the composites in that the more of the non-PVA cryogel 
compound that was added the greater the elastic modulus.  2% CS's modulus was 
1.20MPa and is considered statistically similar to plain 30%.  Doubling the percentage 
weight of chitosan increased the modulus 32% to 1.58MPa.  4% CS is also the only 
sample tested that showed a increase in the modulus from the original.  5% CaPO4 
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showed a 34% reduction from plain 30% PVA cryogel.  Doubling the CaPO4 showed a 
similar increase to the chitosan of 34%. 
In Relation to Facial Implant Criteria 
Most of cartilage falls within an elastic range of [0.3,1.3]MPa, however the 
deepest 20% could increase as high as 2.3MPa.[43]  While none of the samples had a 
modulus as high as 2.3MPa, the elasticity of 30% wt plain PVA cryogel fell within the 
typical cartilage range as did all its porous counterparts. 
The Young's modulus for adipose tissue has been found to range between 0.005-
0.050MPa.[44, 45]  At 0.04MPa, gaseous 20% wt PVA cryogel falls within this range.  
The modulus of plain 10% wt PVA cryogel was 0.08MPa and 10% cast over salt had a 
value of 0.06MPa.  Although larger than the range of human fat, they are within the same 
magnitude. 
In Relation to Shore A Hardness 
The ASTM F881Standard Specification for Silicone Elastomer Facial Implants 
gives a requirement that the durometer shall have a maximum of shore A80.[42]  A 
durometer, which is used to measure the hardness, was unavailable for use during the 
time of experimentation.  To help determine the hardness of the PVA cryogels, an 
equation was found from Qi et al. that converts the Young's modulus to shore A 
hardness.[88]  This equation is shown below, where S is the shore A hardness and E is 
the elastic modulus in units of MPa. 
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After substituting the experimental values of the elastic modulus for each PVA 
cryogel sample into the equation, the shore A hardness conversions are shown in Table 5.  
The largest hardness value found was A43 (4% chitosan and PVA cryogel composite), 
which is well below the A80 requirement for facial implants.  
Table 5: Converting Young's Modulus to Shore A Hardness 
 
 
Maximum Tensile Strength 
For the nonporous PVA cryogel, the maximum tensile strength doubled with each 
10% increase in PVA cryogel within the samples.  Strength increased from 0.39MPa at 
10% wt PVA cryogel to 1.14MPa at 20% wt PVA cryogel to then 2.48MPa at 30% wt 
PVA cryogel.  The standard deviation of all three of them is less than 8.0% of the total 
value. 
The average maximum tensile strength for 30% wt PVA cryogel was slightly 













10% Salt 0.06 9
20% Salt 0.18 15
2% CS 1.2 38
4% CS 1.58 43
5% CaPO4 0.79 31
10% CaPO4 1.06 36
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pressed into it.  The strength was decreased 14% to a value of 2.13MPa.  The 30% wt 
PVA cryogel molded over Velcro had a decrease of 40% from the original to have a 
strength of 1.5MPa.  The imperfections in the solid PVA cryogel created through these 
methods weakened the strength of the 30% wt PVA cryogel. 
20% wt PVA cryogel that underwent the gas method had an average ultimate 
tensile strength of 0.06MPa with a standard deviation of ±0.02.  This is a 95% reduction 
from the plain 20% wt PVA cryogel.  This method created closed pores with diameters 
up to 600µm.  These samples have on average 75% porosity with thin walls separating 
the pores. 
Porous PVA cryogel created through the salt casting and leaching method also 
showed a decrease in tensile strength in comparison to their plain PVA cryogel 
counterparts.  10% wt PVA cryogel with salt decreased 46% to have a strength of 
0.21MPa and 20% salt decreased 78% to 0.25MPa.  Once again, open space from the 
pores greatly impacted the strength of the material.  In addition, both data ranges were 
within each other's standard deviation.  10% salt has a standard deviation range of 
[0.15,0.27]MPa and 20% has a range of [0.12,0.38]MPa.  As presented in Table 7 the 
tensile strengths were compared between both salt weight percents.  With a calculated P-
value of 0.328, there is no statistical difference in strength between them. 
The materials used in the composites were still embedded within the samples 
during the tensile tests.  2% CS had a tensile strength of 1.53 and a standard deviation of 
±0.26.  This is a 38% decrease in strength from the plain 30%.  4% CS had a strength of 
2.54MPa ±0.25 and was the only tested porous PVA cryogel that had a strength 
statistically similar to its nonporous counterpart.  Doubling the percent weight of 
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embedded CS increased the average tensile strength by 40%.  Calcium phosphate was 
also still embedded within the 30% wt PVA cryogel for tensile testing.  5% CaPO4 had 
an average strength of 2.11MPa ±0.26, a 15% decrease from the plain PVA cryogel.  
10% CaPO4 gave the highest value of tensile strength out of all methods at 2.66MPa 
±0.12.  While this is only a 7% increase in strength from the plain 30% wt PVA cryogel, 
a p-value of 0.018 deemed this increase significant. 
In relation to cartilage, an implant should have a minimum strength of 1.71MPa.  
The average tensile strength of cartilage falls between the values found for 20% and 30% 
plain PVA cryogel.  The porous implants that had an average that met this threshold were 
the poked PVA cryogel and the composites made up of 4% CS and 5% and 10% CaPO4.  
The PVA cryogel molded over Velcro and the composite of 2% CS showed averages 
below this threshold, however their standard deviation range did meet this standard. 
Yield Elongation Percentage  
A graph comparing the elongation percentage of all the samples is exhibited in 
Figure 30, and the statistical comparison is listed in Table 7.  Plain 10%, 20%, and 30% 
wt PVA cryogel all have a similar yield elongation strain of 250, 275, and 268% 
respectively.  Each of their standard deviations fell within each other's range.  
The PVA cryogel poked with holes and the Velcro both show a decrease in yield 
elongation percentage from the plain 30% wt PVA cryogel.   The poked holes samples 
have an average decrease of 32% to an elongation of 181% and  the Velcro mold has a 
elongation value of 200% which is a 25% reduction.  These values fall within each 
other's standard deviation ranges [162,200] and [160,240] respectively.   
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Gassed 20% wt PVA cryogel had a ride range of sampled elongation.  Sample 5 
had an elongation of 76% while Sample 3 was found to be 224%.  The average was 
154%, which is a 44% decrease from plain 20%. 
10% salt had the highest average elongation percentage at 396% ±98.  This is a 
158% increase from plain 10% PVA cryogel. 20% PVA cryogel with salt had the second 
lowest at 163% ±92 which was a 41% decrease in average.  The elongation percent was 
reduced 40% from 10% to 20% salt. 
Most of the composite materials maintained similar elongation percentages to the 
nonporous PVA cryogels.  With an elongation of 207%, 2% CS had a significant 
reduction of 22% from plain 30% wt PVA cryogel.  However 4% CS, 5% CaPO4, and 
10% CAPO4 all had elongation percentages that were not considered statistically 
significant from 30%. 
In general, a trend can be seen that PVA cryogel with unfilled pores have a 
reduced elongation percentage than that of plain and composite PVA cryogel.  PVA 
cryogel that was poked, molded with Velcro, gassed, and cast with 20% PVA cryogel all 
showed this.  The only one that was different was that of 10% salt.  Those that had 
particles embedded within it showed similar elongations except for 2% CS.  2% CS has 
four samples with a standard deviation 20% of the average’s value.  Sample 4 of 2% CS 
extended to 263% of its original length.  This shows that it is possible for 2% CS to have 
a similar elongation the rest of the composite materials which can possibly be achieved 
with better manufacturing practices.  In addition, those with unfilled pores also tended to 
have larger standard deviations percentages than the other types of PVA cryogel.  This 
could be because of the variability in size and position of formed pores. 
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The threshold for yield elongation percentage was decided to be similar to that of 
cartilage: 30%.  All tested materials easily achieved this benchmark.  The lowest 
elongation found, gaseous 20% PVA cryogel at 154% elongation, is over 500% larger 





Table 6: Calculated Tensile Strength, Elongation, and Young's Modulus  


















1 10.72 2.79 0.41 268 0.07
2 10.78 2.93 0.34 251 0.06
3 11.16 2.33 0.43 262 0.09
4 12.18 2.65 0.39 252 0.08
5 11.67 2.18 0.39 215 0.09
6 11.3 2.77 0.25 177 0.11
7 11.6 2.08 0.51 218 0.12
Average 0.39 250 0.08

















1 11.26 2.66 1.090 293 0.209
2 11.43 2.54 1.181 279 0.252
3 11.92 2.74 1.038 263 0.248
4 11.24 2.85 1.245 277 0.266
Average 1.14 278 0.24

















1 12.50 4.17 2.554 291 1.248
2 11.82 3.62 2.532 248 1.168
3 11.90 3.55 2.500 280 1.171
4 12.42 3.72 2.323 242 1.193
Average 2.48 265 1.20























1 11.71 3.40 2.33 204 1.22
2 11.77 4.23 1.82 159 1.24
3 11.52 3.82 2.27 197 1.23
4 11.02 3.15 2.17 181 1.09
5 11.66 3.58 2.06 166 1.40
Average 2.13 181 1.24

















1 10.40 3.05 1.92 240 0.82
2 9.49 2.75 1.34 153 1.02
3 11.22 3.12 1.48 226 0.81
4 10.40 3.15 1.28 183 0.87
Average 1.50 200 0.88

















1 12.00 2.78 0.06 114 0.04
2 11.47 4.25 0.06 215 0.03
3 10.90 2.66 0.11 224 0.04
4 11.66 3.74 0.06 148 0.03
5 11.81 3.50 0.04 76 0.04
6 11.22 4.00 0.05 124 0.04
7 11.60 3.60 0.07 177 0.03
Average 0.06 154 0.04




























1 10.50 5.16 0.31 380 0.06
2 10.10 6.31 0.17 387 0.06
3 11.09 5.80 0.18 590 0.06
4 10.00 4.52 0.17 327 0.06
5 10.90 4.71 0.20 335 0.05
6 8.48 4.35 0.26 357 0.07
Average 0.21 396 0.06

















1 11.15 6.35 0.19 112 0.17
2 11.37 6.06 0.21 122 0.17
3 12.04 7.30 0.43 301 0.24
4 11.66 6.79 0.15 117 0.15
Average 0.25 163 0.18

















1 11.65 4.30 1.56 214 1.24
2 11.43 4.01 1.24 178 1.03
3 11.30 3.88 1.46 175 1.15
4 11.57 4.30 1.87 263 1.37
Average 1.53 207 1.20
Stdev 0.26 41 0.14
Salt    
10% PVA




























1 11.40 4.53 2.42 267 1.57
2 11.51 4.30 2.83 280 1.68
3 11.66 4.59 2.36 267 1.50
Average 2.54 271 1.58

















1 11.88 4.24 1.95 305 0.74
2 12.20 3.38 2.40 286 0.77
3 12.30 4.03 2.25 281 0.80
4 12.35 4.12 1.85 279 0.84
Average 2.11 288 0.79

















1 11.86 3.30 2.77 305 1.04
2 11.63 3.43 2.73 286 1.05
3 11.30 3.45 2.46 281 1.13
4 11.62 3.50 2.57 279 1.00
5 11.40 3.49 2.77 267 1.07
6 11.99 3.42 2.67 276 1.08
Average 2.66 282 1.06












Figure 29: Comparison of Tensile Strengths for Porous PVA cryogel 
Red line notes the acceptance criteria of 1.71MPa 
 
 
Figure 30: Comparison of Elongation Percentages for Porous PVA cryogel 






































































Figure 31: Comparison of Elastic Modulus for Porous PVA cryogel 
Red line notes the acceptance criteria range for cartilage [0.3,2.3]MPa.  Green line notes the 
acceptance criteria range for adipose tissue [0.005,0.05]MPa. 
 
Table 7: Tensile Strength and Elastic Modulus Statistical Significance Comparison 

















































10% PVA 20% PVA 0.000 0.007 0.000
20% PVA 30% PVA 0.000 0.195 0.000
30% PVA Poked 0.015 0.001 0.238
30% PVA Velcro 0.002 0.019 0.002
20% PVA Gas 0.000 0.000 0.000
10% PVA 10% Salt 0.000 0.004 0.008
20% PVA 20% Salt 0.000 0.043 0.018
10% Salt 20% Salt 0.328 0.003 0.003
30% PVA 2% CS 0.001 0.031 0.481
30% PVA 4% CS 0.360 0.333 0.005
2% CS 4% CS 0.002 0.026 0.004
30% PVA 5% CaPO4 0.030 0.080 0.000
30% PVA 10% CaPO4 0.018 0.128 0.001




Tear strength (Ts) is calculated in kiloNewtons per meter (kN/m) of thickness by 
the formula 




Where F is the maximum force (in Newtons) obtained from the test and d is the 
median thickness of each piece in milimeters. 
Samples were tested in tension using the 'zig-zag' shape shown in Figure 11 
according to standard ASTM D624.  The thickness of each sample was noted before 
every test and is listed along with the calculated tear strength in Table 8.  A graphical 
representation is displayed in Figure 32 and statistical data to determine significant 
difference is shown in Table 9. 
Tear strength for plain 10% wt PVA cryogel was found to be 1.345kN/m.  It was 
found to have increased 40% to 2.26kN/m for 20% wt PVA cryogel and quadrupled to 
9.11kN/m for 30% wt PVA cryogel. 
An increase in the average value was seen in samples that were composed of plain 
PVA cryogel. 
The 30% PVA cryogel that was poked with holes increased in tear strength by 
30% to become 13.06kN/m.  The one molded with Velcro showed a 20% increase from 
plain 30% wt PVA cryogel, however with a P-value of 0.079 it is not considered 
statistically significant.  Reducing the standard deviation of 30% wt PVA cryogel through 
more samples could likely show that there is an increase. 
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Using the gas method on 20% wt PVA cryogel reduced the tear strength 74% to 
0.585kN/m.  This is the lowest tear strength found out of all the samples. 
While there is an increase on the average value of the tear strength of the salt 
method, the change was not statistically significant in comparison to the plain 
counterparts.  10% salt had an average increase of 38% but the P-value was 0.071.  20% 
salt showed an average increase of 30% but had a P-value of 0.083.  A 58% increase was 
seen between 10% salt and 20% salt. 
 While increasing chitosan increased tear strength, the opposite was true for 
CaPO4.  2% CS showed an average increase from plain 30% wt PVA cryogel of 25% to 
make the average 11.36kN/m, but a P-value of 0.094 makes the difference not significant.  
4% CS had a value of 15.31kN/m and is a 35% increase from the 2% CS composite.  The 
CaPO4 composites were both found to not be statistically significant from plain 30%.  





Table 8: Calculated Tear Strength 
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Figure 32: Comparison of Tear Strength for Porous PVA cryogel  
 
Table 9: Tear Strength Statistical Significance Comparison 







































Strength      
P-value
10% PVA 20% PVA 0.001
20% PVA 30% PVA 0.007
30% PVA Poked 0.025
30% PVA Velcro 0.079
20% PVA Gas 0.000
10% PVA 10% Salt 0.071
20% PVA 20% Salt 0.083
10% Salt 20% Salt 0.027
30% PVA 2% CS 0.094
30% PVA 4% CS 0.005
2% CS 4% CS 0.010
30% PVA 5% CaPO4 0.164
30% PVA 10% CaPO4 0.470





Figure 33: Images of Plain 10%, 20%, and 30% wt PVA cryogel 
(A) 10% 2X Magnigication (B) 10% 2X Mag (C) 20% 2X Mag (D) 20% 2X Mag (E) 30% 2X Mag (F) 
30% 2X Mag 
 
Microscope images of the PVA cryogel samples are shown in Figure 33 through 
Figure 41.  Table 10 is provided at the end of this section with a summary of the pore 
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sizes.  The left side of Figure 33 displays images of the plain 10%, 20%, and 30% wt 
PVA cryogel at 2X magnification.  The ridges seen are from the blade cutting the PVA 
cryogel.  To show that PVA cryogel does not have any micropores, pictures of the 
samples were also taken at 20X magnification.  From the images it can be seen that PVA 
cryogel is nonporous at 10%, 20%, and 30% wt.  
Pressed Method 
Figure 34 shows a section cut perpendicular to the direction that a 1mm diameter 
needle was pressed into 30% wt PVA cryogel.  While the diameter of the needle used is 
larger than the desired pore size for cellular ingrowth, this method left smaller diameter 
pores.  The range of pore diameters were between 60-170µm with an mean of 125µm.  
The pores created have on average a diameter 88% less than the needle used to create 
them.  The smaller holes can be attributed to PVA cryogel’s elastic nature.   
 
Figure 34: Sectioned Images of 30% wt PVA cryogel pressed with a 500µm needle 
Molded Method 
The images of Velcro are shown in Figure 35.  Unlike the pores created by 
pressing in a needle through a solid block of PVA cryogel after it had undergone 
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freeze/thaw cycles, these were made by molding PVA cryogel over Velcro strips then 
running freeze/thaw cycles.  This method involves molding the PVA cryogel around 
Velcro pillars instead of removing hydrogel material.  Part A of Figure 35 was sectioned 
parallel to the Velcro pad that the PVA cryogel was molded over.  The pattern of the 
Velcro is clearly visible.  These holes were found to have a diameter of 250µm.  The 
sample shown in Part B was sectioned perpendicular to the Velcro pad.  This angle shows 
the depth the Velcro penetrated the PVA cryogel.  The outline of the Velcro shape can 
been seen as a thin cylinder that ends at a larger sized diameter half spherical cap.  The 
depth of the Velcro was measured to be about 1mm. 
  
Figure 35: Sectioned Images of PVA cryogel Pressed with Velcro 
(A) Sectioned parallel to the Velcro pad (B) Sectioned perpendicular to the Velcro pad 
Casting/Particulate Leaching Method 
Salt with diameters ranging from 150-600µm were used for the solvent casting/ 
particulate leaching method.  Images of the formed pores are shown in Figure 36.  Part A 
shows 10% wt PVA cryogel pressed into the salt.  Most of the pores are shown to be 
open and connecting to multiple other porous spaces.  The pore size ranged from 100-
800µm with a mean size of 450µm.  Part B shows the 20% wt PVA cryogel pressed into 
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salt.  The pores are less interconnected and smaller than the 10% wt PVA cryogel cast 
over salt.  The pore range was found to be 50-250µm with a mean of 150µm.  The pores 
also have less of a defining shape to them while the pores from 10% wt PVA cryogel are 
mostly in the shape of squares with curved corners, i.e. the shape of the salt.  In addition, 
the 10% wt PVA cryogel could be pressed up to 3cm in depth into the salt.  The depth of 




Figure 36: Sectioned Images of PVA cryogel pressed into salt crystals 






Figure 37 is an image of porous PVA cryogel created through the gas method.  
These pores are more circular in shape and have defined boarders.  This shows that the 
pores are less interconnectivity than that of salt.  Pore sizes ranged from 20-600µm with a 
mean of 220µm and they proliferated throughout the PVA cryogel sample but not 
uniformly. 
 
Figure 37: Sectioned Image of Porous PVA cryogel Created Through Gas Method 
PVA cryogel/CS Composite Method 
The flakes of chitosan were combined with the PVA cryogel in the autoclave to 
create the composite material were imaged with the microscope and are shown in Figure 
38.  The small flakes range in size from 5-15µm.  There are also larger flakes present that 
have diameters as large as 200µm.  Sections of the produced PVA cryogel/CS composite 
are shown in Figure 39.  Part A displays 30% wt PVA cryogel mixed with 2% chitosan.  
The pore range is 20-300µm with a mean of 80µm.  The larger pores are most likely from 
when some chitosan clumped together as well as from some of the larger CS flakes.  Part 
B displays PVA cryogel mixed with 4% chitosan.  The pores ranged from 20-500µm with 
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a mean of 100µm.  The higher prevalence of larger sized pores can be attributed to the 
larger quantity of CS added to the mixture and which led to more clumping of the flakes. 
 
Figure 38: Image of Chitosan Flakes 
  
Figure 39: Sectioned Images of PVA cryogel mixed with Chitosan  
(A) 2% CS (B) 4% CS 
PVA cryogel/CaPO4 Composite Method 
PVA cryogel was cooked with CaPO4 powder to create the final porous 
composites.  Images of the CaPO4 powder are shown in Figure 40.  The small dots 
pictured are between 3 and 5µm in size.  The larger dots are from the CaPO4 clumping 
together and are both 50µm in diamteter. Finally, Figure 41 displays 30% wt PVA 
cryogel mixed with calcium phosphate.  Part A shows the sample at 2X magnitude while 
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Part B is at 10X magnification.  These small black dots are the CaPO4 embedded within 
the PVA cryogel.  Pore sizes range from 5-15µm with a mean of 8µm.  Part C is a section 
of PVA cryogel with 10% CaPO4 added and it is magnified in Part D.  It can be observed 
that the 10% CaPO4 images are slightly darker than their 5% counterparts because a 
higher density of the embedded compound.  The pore range for 10% CaPO4 is 5-20µm 
with a mean of 10µ.   
 





Figure 41: Sectioned Images of PVA cryogel mixed with CaPO4 
(A) 5% CaPO4 (B) Close up of 5% CaPO4 (C) 10% CaPO4 (D) Close up of 10% CaPO4  
In Relation to Facial implant Criteria 
The pore size range, mean pore size, interconnectivity of the pores, and the depth 
of the pores is summarized in Table 10.  Fibrous ingrowth can be seen in pores with 
diameters between 5 and 15µm while bone regeneration typically requires pore diameters 







Table 10: Pore Size Range and Interconnectivity of Manufactured Porous PVA cryogel 
 
 
The pores of the 30% PVA cryogel pressed with a needle had a diameter range of 
60-170µm.  The 1mm diameter needle used was thick enough to create some pores that 
will encourage bone growth.  A larger mean pore size can be obtained by using a larger 
needle and a smaller one can lead the pores to be within the fibrous ingrowth range if 
desired.  The consistent pore size of 250µm created by molding the PVA cryogel over 
Velcro shows that it can be used to encourage bone ingrowth.  Again, changing the size 
of the extrusions can alter the pore size to be as large or as small as desired.  
Implants that become interconnected to the neighboring bone will be then 
anchored to the bone and are less likely to migrate.  Preventing the implant from creating 
dissymmetry or noticeable imperfections is critical when dealing with facial implants.  
Based on their pore size range, 10% salt, 20% salt, gaseous PVA cryogel, and both 
chitosan composites would all allow bone ingrowth.  All their mean pore diameters were 
100µm or above as well except for 2% CS with a measured mean diameter of 80µm.  




Mean  (µm) Interconectivity Depth (mm)
Poke 30 60-170 125 Unidirectional Throughout
Velcro 30 250 250 Unidirectional 1
Salt 10 100-800 450 Yes 3
Salt 20 50-250 150 Yes 1-1.5
Gas 20 20-600 220 No Throughout
2% CS 30 20-300 80 Partial Throughout
4% CS 30 20-500 100 Partial Throughout
5% CaPO4 30 5-15 8 No Throughout
10% CaPO4 30 5-20 10 No Throughout
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bone ingrowth.  Doubling the chitosan to 4% CS showed a 20µm increase in mean pore 
size to 100µm. 
Both 5% and 10% CaPO4 had pore sizes that fell within the fibrous ingrowth 
range (5-15µm and 5-20µm respectively).  While this does not give the strength that bone 
ingrowth would give, it does allow some stability.  In addition, implants with fibrous 
ingrowth cause little tissue damage to its surrounding area when removed.  PVA 
cryogel/CaPO4 composites could be used in the case of temporary implants where they 





The ratio of porosity was determined through image analysis in Matlab.  Figure 
42 displays examples of the microscope images before and after they were analyzed.  Part 
A shows an image of gaseous PVA cryogel then Part B displays it after it was 
transformed into a 2-tone black and white image.  Part C and D show the same process 
for the CaPO4 images. 
 
Figure 42: Before/After Images converted in Matlab to obtain porosity percentage 
(A) Image of porous PVA cryogel obtained through gas method (B) 2-Tone black/white image (C) 
Image of porous PVA cryogel/CaPO4 composite (D) 2-Tone black/white image 
In Relation to Facial Implant Criteria 
The average porosity ratios of the manufactured porous PVA cryogel are 
presented in Table 11.  The porosities listed were found through the created Matlab 
Microscope Image Microscope Image
Microscope Image Black/White Image Rendering
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function.  The images used to measure porosity were from multiple molded samples per 
batch of manufactured PVA cryogel and at least two separate batches were made at 
different times.  The higher the porosity percentage of a material, the more structural 
linkage of the ingrowth material within the implant to ensure attachment and prevent 
slippage.  An implant should strive to have a minimum porosity of 30%  to help this 
bonding.[52]  The samples that meet this minimum are gaseous PVA cryogel (74%) and 
those cast over salt (61% and 31%).   
Table 11: Porosity Ratio of Manufactured Porous PVA cryogel 
 
  
% wt PVA 30 30 20 10 20 30 30 30 30
Samples Poked Velcro Gas 10% Salt 20% Salt 2% CS 4% CS 5% CaPO4 10% CaPO4
0.05 0.09 0.80 0.73 0.35 0.13 0.20 0.16 0.23
0.08 0.14 0.72 0.68 0.37 0.12 0.15 0.17 0.20
0.03 0.09 0.69 0.71 0.30 0.10 0.17 0.18 0.24
0.02 0.12 0.78 0.68 0.24 0.12 0.17 0.14 0.23
0.03 0.18 0.67 0.72 0.27 0.09 0.21 0.17 0.23
0.01 0.10 0.76 0.67 0.26 0.10 0.20
0.03 0.15 0.31 0.31 0.17 0.16
0.01 0.03 0.38 0.38
0.01
Average 0.03 0.10 0.74 0.61 0.31 0.12 0.18 0.16 0.23










Only the plain PVA cryogel underwent tests to determine its increase in volume 
from a dehydrated to rehydrated state.  Each sample was dried one week to remove all 
water then was placed in deionized water for two weeks.  The results are listed in Table 
12 and are compared in Figure 43. 
Density of the samples was determined by weighing a large sample then 
measuring its volume in a graduated cylinder.  With all water removed, the composition 
for each would only be made of PVA cryogel.  This would lead one to expect the 
densities of the dried PVA cryogels would all have similar densities.  The dried 10%, 
20%, and 30% had densities 1.13, 1.12, and 1.14g/mL respectively.  The values are 
within 1% of each other.   After swelling, it can be seen that the densities increased with 
increasing weight percent.  The densities of 10%, 20%, and 30% wt PVA cryogel became 
1.03, 1.05, and 1.08g/mL respectively.  Since 10% PVA cryogel has the highest water 
content per weight, it is expected that it would have the density closest to water 
(1.00g/mL).   
The weight of five samples was measured for each weight percent then volume 
was calculated from this and the density.  The change in the calculated volume from the 
dehydrated to hydrated state is the swelling ratio.  10% wt PVA cryogel showed an 
increase in volume of 250% from a dried sample.  20% wt PVA cryogel had an increase 
of 240% and 30% was 197%. 
The swelling data collected show the beginning of a trend in which the swelling 
ratio decreases with the increase of PVA cryogel weight percent.  10% wt PVA cryogel 
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contains the highest percentage of water, so was expected to have a larger volume change 
from hydrated to dried and vise versa. 


















1 0.39 0.35 1.29 1.26 262
2 0.64 0.56 1.96 1.91 239
3 0.37 0.33 1.21 1.18 261
4 0.79 0.70 2.35 2.29 228


















1 1.21 1.07 3.853 3.68 243
2 1.09 0.97 3.443 3.29 238
3 0.89 0.79 2.833 2.71 242
4 1.27 1.13 4.083 3.90 245


















1 1.39 1.22 4.02 3.72 205
2 2.457 2.16 6.68 6.18 186
3 2.23 1.96 6.11 5.66 189
4 1.08 0.95 3.06 2.84 200

















A summary of all calculated values of mechanical and porous characteristics is displayed in Table 13. 




% wt PVA 10 20 30 30 30 20 10 20 30 30 30 30
Sample 10% 20% 30% Poked Velcro Gas 10% Salt 20% Salt 2% CS 4% CS 5% CaPO4 10% CaPO4
Young's Modulus (MPa) [0.005,0.05] 0.08 0.24 1.20 1.24 0.88 0.04 0.06 0.18 1.20 1.58 0.79 1.06
Tensile Strength (Mpa) ≥1.71 0.39 1.14 2.48 2.13 1.50 0.06 0.21 0.25 1.53 2.54 2.11 2.66
Elongation (%) ≥30 250 278 265 181 200 154 396 163 207 271 288 282
Tear Strength (kN/m) ≥2.0 1.34 2.26 9.11 13.06 11.59 0.58 1.85 2.92 11.36 15.31 10.76 9.00
Pore Size (µm) [10,30] , [100,700] - - - 60-170 250 100-800 50-250 20-600 20-300 20-500 5-15 5-20
Porosity (%) [30,90] - - - 3 10 74 61 31 12 18 16 23







Many of the materials of the formulations tested would meet the goal of 
simultaneously achieving softness ([0.005,0.05]MPa for fat, [0.3,2.3]MPa for cartilage), 
surface porosity (≥0.3), and swelling ratio (≥0.5) for facial implants that are significantly 
better than the current devices.  The selection of the best material for a particular implant 
would depend on the intended use.  For instance, a nasolabial fold implant should have 
the softness of fat with light porosity, and more swelling.   However, an ear implant 
should be stiffer like cartilage and have a small dimensional swelling.   
Mechanical Properties 
In respect to facial implants such as those for the nose and chin, the FDA 
recommends potential materials to undergo tests described in ASTM F881.  These 
include tensile and tear tests to determine the material's tensile strength, yield elongation, 
modulus of elasticity, and tear strength.  These mechanical properties of popular 
biomaterials on the market have been determined and are listed for reference in Table 14.  
The values for silicone are from the 510(k) summary for silicone facial implants by 








Table 14: Mechanical Properties of Popular Biomaterials 
Property Silicone Medpor Gore-Tex 
Tensile Strength (MPa) 6.55 23 12 
Elongation (%) 650 4 600 
Young's Modulus 
(MPa) 
2.07 227-307 6 
Tear Strength (kN/m) 1.03 45 179 
Reference  [89] [21, 90-92]   [92-94] 
 
Elasticity 
 In the literature, the rigidity of the implant was constantly mentioned as an issue 
with current facial implant materials.  As seen in Table 14, the Young's modulus' for 
silicone, Medpor, and Gore-Tex are 2.07MPa, 227-307MPa, and 6MPa respectively.  The 
elastic range of cartilage is [0.3,2.3]MPa.  All the porous PVA cryogel samples made 
with 30% wt PVA cryogel fell within this range for cartilage.  The same cannot be same 
for other biomaterials.  Silicone with a modulus of 2.07MPa is the only one within the 
range of softness.  Since the Young's modulus of cartilage increases as the depth of 
cartilage increases, 2.07MPa only falls within the range of the lowest depth (bottom 20%) 
of cartilage.  Gore-Tex is much more ridged than cartilage with a modulus of 6MPa while 
Medpor is more similar to bone than cartilage.  With a value that range from 227-
307MPa, Medpor is the most rigid option used for facial implants and is two magnitudes 
greater than that of cartilage.  One of the most common complaints for Medpor is that its 
stiffness makes it feel unnatural.  With an elastic modulus that falls within the range of 
cartilage, porous PVA cryogel made with 30% wt PVA cryogel can offer a more natural 
feeling implant to the patient. 
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The modulus of elasticity of adipose tissue was found to range from 0.005-
0.050MPa.  10% wt PVA cryogel cast over salt and gaseous 20% wt PVA cryogel met 
this criteria.  These mechanical properties cannot be compared directly to those of 
popular dermal fillers due to their fluid nature.  For general purposes, though, the elastic 
modulus of poly(methyl methacrylate) (PMMA) was found.  This is the material of the 
only permanent dermal filler option and it is administered in the shape of microspheres.  
The Young's modulus of this material can range from 1800-3100MPa.[95]  With the 
modulus of PMMA being five magnitudes greater than the surrounding tissue, the porous 
PVA cryogel samples would have a more natural feel underneath the skin. 
Tensile Strength 
The minimum tensile strength for a cartilage replacement was found to be 
1.71MPa.[46]  When looking at some of the most common biomaterials, it can been seen 
that they all have a tensile strength much higher than cartilage.  Silicone is the closest and 
it is more than triple the minimum value.  Gore-Tex has a tensile strength six times 
greater than cartilage, and Medpor is a whole factor greater at 23MPa. All tensile 
strengths determined from the created samples are closer in value to cartilage than those 
of current biomaterials, and all the porous PVA cryogel made with 30% wt PVA cryogel 
met this minimum standard. 
Elongation 
The standard recommendations by the FDA[42] states the elongation percentage 
of a cartilage replacing implant should be at least 200%.  Since cartilage deformation 
begins after a 30% change in length, this value was chosen as the minimum elongation.  
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All porous PVA cryogel samples met this threshold.  Silicone met the 200% elongation 
requirement of ASTM F881 with a value of 650% as did Gore-Tex with a value of 600%.  
Medpor, however, only has an elongation of 4% before it breaks.  Having an implant that 
can stretch to at least the length of the surrounding tissue can help prevent an implant 
from having a unnatural feel, especially one in the face that is regularly under stress.  In 
regards to elongation, all the porous PVA cryogel samples created would be more suited 
than Medpor for facial implants. 
Tear Strength 
The FDA does not have a recommended tear strength for facial implants, but 
cartilage was found to have a tear strength range of [2.0,2.4]kN/m.[48]  An implant 
should have the same tear strength as cartilage if not higher to prevent it from becoming 
damaged.  Both plain 20% and 30% wt PVA cryogel have a tensile strength of at least 
2.0kN/m as well as almost all of their porous counterparts.   
In comparison to other biomedical implants, silicone actually has tear strength 
beneath that of cartilage at 1.03kN/m.[96]  This could lead it to tear internally while the 
surrounding cartilage stays intact, however none of the literature reviewed listed this 
occurrence.  Only gaseous PVA cryogel presented a lower value, thus all but gaseous 
PVA cryogel would be an improved implant than silicone in regards to tear strength.  
Both Medpor and Gore-Tex have strengths magnitudes greater than cartilage at 45kN/m 





Summary of Mechanical Characteristics 
While the elastic modulus of cartilage typically ranges from 0.3 to1.3MPa, it can 
be as high as 2.3MPa.  30% wt PVA cryogel and all its counterparts were found to have a 
Young's modulus within this range.  Their values are more similar to that of cartilage 
than those materials on the market that can be as high as 23MPa.  30% wt PVA cryogel 
and all its porous counterparts either are the same tensile strength range as cartilage or are 
within the same magnitude while current biomaterials are many times greater.  The 
elongation percentage of every sample was found to be greater than 30% (the maximum 
of cartilage).  The required minimum tear strength to match cartilage was found in all 
samples except 10% wt and gaseous PVA cryogel.  When comparing all mechanical 
properties, the values of the porous samples made with 30% wt PVA cryogel have 
equivalent values to cartilage unlike current biomaterials. 
In regards to a filler for adipose tissue, the elasticity range is 0.005-0.05MPa.  
10% wt PVA cryogel, its salt porous counterpart, and gaseous PVA cryogel all had 
similar elastic moduli.  These were 0.08MPa, 0.21MPa, and 0.06MPa respectively.  
While elasticity cannot be compared directly to current dermal fillers, the material of the 
microspheres within the permanent filler (PMMA) has a modulus five magnitudes greater 
than fat.  These porous PVA cryogels have a softness equivalent to that of adipose tissue 
unlike the current permanent option for patients in regards to dermal fillers. 
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Pore Structure Characteristics 
Pore size and porosity percentages were determined by sectioning and imaging 
the implant.  These values can be used to determine the likelihood of cellular ingrowth 
and eventual implant attachment after implantation.  A wide range of pores and 
interconnectivity were observed with the created porous PVA cryogel samples.  
Information about these different pore structures show that some of the porous implants 
would have a greater chance of cellular ingrowth than others. 
Pore Size 
As stated earlier, fibrous ingrowth can be seen in pores with diameters between 5 
and 15µm while bone regeneration typically requires pore diameters ranging from 100 to 
400µm but can be as high as 700µm.[49-51]  A chart comparing the porous PVA 
cryogel's pore range values to those of cellular ingrowth and current biomaterials is 
shown in Figure 44. 
 
Figure 44: Comparison of Pore Ranges 
Compares Cellular Ingrowth Ranges, PVA cryogel Samples, and Current Biomaterials 
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Having a porous implant, regardless of the pore diameter, allows for the body's 
surrounding environment to grow into it.  All the porous samples manufactured are 
superior to nonporous silicone in this regard.  Medpor has a pore diameter range of 100-
250µm which is suitable for bone growth.  Five of the porous PVA cryogel samples 
created also meet this standard.  Gore-Tex is considered to be a microporous structure.  
Its pore range is 10-30µm which allows fibrous ingrowth.[97]  The microporous calcium 
phosphate composites manufactured are then similar in utility. 
Porosity 
The higher the porosity percentage of a material, the more structural linkage of 
the ingrowth material within the implant to ensure attachment and prevent slippage.  An 
implant should strive to have a minimum porosity of 30%  to help this bonding.[52]  The 
samples that meet this minimum are gaseous PVA cryogel (74%), those cast over salt 
(61% and 31%), and the CaPO4 composites (59% and 67%).  A graph of the porosities of 
the samples is shown in Figure 45 with the red line marking the 30% minimum. 
In relation the current biomaterials on the market, all the porous PVA cryogel 
samples created have an advantage over silicone in regards to porosity.  One reason for 
silicone's decrease in popularity in America is due to its high likelihood of movement and 
rejection from the body.  Having porous PVA cryogel allows the body to grow into the 
implant and prevent it from shifting.  Both Medpor and Gore-Tex both have porosities 
above 30% (46% and 70% respectively).  Bone ingrowth has been proven to occur within 
Medpor within two weeks of implementation.[90] Fibrous ingrowth has been seen within 




Figure 45: Comparison of Porosities 
Red line marks minimum porosity needed for intercellular linkage during ingrowth 
Surface Texture 
In this research, porous PVA cryogel was created to allow cellular ingrowth into 
facial implants.  This causes the implant to have a textured surface instead of a smooth 
one.    While the merits of a smooth verses textured implant surface has not been 
researched for facial implants, they have been extensively studied with breast implants in 
relation to capsular contracture.  This is the occurrence when the scar tissue that forms 
around the implant contracts and tightens.  This can lead to an aesthetic change of the 
implant and discomfort for the patient.  If the capsular contracture is severe enough, it 
must be corrected by surgery.[98] 
There is overwhelming evidence that suggests that the type of textured breast 
implants have a lower capsular contracture rate than smooth ones.  Barnsley et al. 

























Comparison of Porosity 
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that smooth surfaced implants are five times more likely to have capsular contracture 
occur. Wong el al., in another review of previous studies, also found that textured 
implants experience capsular contracture less than smooth implants as well as it was 
independent of the pore size (30-70µm and 300-800µm) of the textured implant.[99]  
Collis et al. studied the long term affects of breast implants surfaces at ten years after 
implantation.  He observed a capsular contracture rate of 65% for patients with smooth 
implants compared to 11% of textured.[100] 
While there is not research that compares surface texture to the rate of capsular 
contracture in facial implants, studies show the benefit of textured breast implants over 
smooth implants.  If this is the same for facial implants, then this suggests another benefit 
of the manufactured porous PVA cryogel implants in this study in comparison to current 
silicone facial implants as well as those made with plain PVA cryogel. 
Summary of Porous Characteristics 
Both the pore size and the porosity percentage are important for cellular ingrowth.  
The pore size determines ingrowth type while a high porosity allows the tissue to 
interconnect and create a strong hold between the implant and the surrounding area.  In 
addition, the texturing of the implant can possibly prevent capsular contraction.  The salt 
samples and gaseous PVA cryogel, and the chitosan composites all have pore sizes that 
will allow for bone ingrowth.  The fine powder of the calcium phosphate created a 
microporous composite which is more suitable for fibrous ingrowth.  In regards to a 
minimum porosity, the PVA cryogel cast over salt and gaseous PVA cryogel both 
presented a porosity high enough to allow tissue interconectivity.  Thus, when 
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considering porous structure, the salt and gaseous PVA cryogel are suitable for bone 
ingrowth.  Although the 30% PVA cryogel that was poked and molded do not meet these 




Comparing Porosity to Mechanical Properties 
The porosity of the materials was compared to the mechanical characteristics to 
identify any trends.  Scatter plots comparing these characteristics are displayed in Figure 
46 and Figure 47.  The most obvious trend can be seen with comparing porosity to tear 
strength (the red squares in the plot).  An inverse relation is observed between them.  
Those with higher porosities were found to have lower tear strengths.     
 Trends are not as obvious with Young's modulus (green triangles) and 
tensile strength (blue diamonds).  Below a level of 30% porosity, these two mechanical 
values are scattered without noticeable trends.  Above a level of 30% porosity, there is a 
clear drop in the Young's modulus and tensile strength values as compared to the values 
below 30%.  A value of approximately 30% porosity appears to be a threshold of some 
type. 
 
Figure 46: Comparing Mechanical Properties to Porosity 







































































Tear Strength vs Porosity 
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Rule of Mixtures 
After the material mechanical characteristics were determined experimentally, 
they were compared to their theoretical values calculated using the rule of mixtures.  The 
general rule of mixtures is used in material science as a means to predict the mechanical 
properties of composite materials, including the elastic modulus.[101]  The rule of 
mixtures uses the elastic modulus of the matrix material (Em) and of its reinforcement 
fiber material (Ef) to calculate the elastic modulus of the composite.  The volume fraction 
of the reinforcement material is identified as vf.  These series of equations can calculate 
the elastic modulus when the reinforcement fibers are in three positions.[102, 103]  When 
the fibers are parallel to the direction of the applied force, the longitudinal modulus (EL) 
can be calculated using the following equation. 
                 
The transverse modulus (ET) is the elastic modulus when the direction of the 
fibers in perpendicular to that of the applied force.  This is shown in the equation below. 
   
    
             
 
Finally, the longitudinal and transverse modulus can be combined to find the 
random modulus (ER) in which there is no order to the direction of the fibers.  The 
equation is shown below. 
   
 
 
   
 
 
   
Em was obtained from the mechanical testing.  The elastic moduli for 10, 20, and 
30% wt PVA cryogels were found to be 0.08, 0.24, and 1.20MPa respectively.  The 
120 
 
values for Ef were found in literature: 65MPa for chitosan [104] and 100MPa[105] for 
calcium phosphate.  Ef for air is zero. 
A table showing the calculations for EL, ET, and ER are shown in Table 15.  A 
graph comparing the theoretical longitudinal elastic moduli (EL) to those found through 
mechanical testing is shown in Figure 48.   
For the poked and Velcro PVA cryogels, the theoretical elastic moduli values 
were 1.16 and 1.08 MPa, which represent differences of 6 and 23% from their respective 
valves found through mechanical testing.  The elastic modulus of porous PVA cryogel, 
which was created using the gas method, was found to be 0.06MPa, which is 50% greater 
than the 0.04 MPa found through experimental methods.  When comparing the theoretical 
and experimental elastic results from the porous PVA created using salt, the theoretical 
values were 48% and 9% less than what was found experimentally for 10% and 20% 
respectively.  The chitosan composite had theoretical elastic values about eight times 
greater than the experimental ones and the calcium phosphate theoretical values were 
twenty-two times greater. 
All of the non-composite porous PVA cryogels created were found to have elastic 
moduli within the same order of magnitude that were found experimentally and within 
50% of those value.  The composites, however, had theoretical values that were much 
greater than the experimental values.  The purpose of the rule of mixtures is to predict 
mechanical values of composite materials.  The input values used to determine these 
theoretical values included some found experimentally (porosity of the composites and 
the elastic modulus of plain PVA cryogel) and in literature (elastic modulus' of chitosan 
121 
 
and calcium phosphate).  Having incorrect values for any one of these inputs could have 
altered the theoretical output from the rule of mixtures and have caused this discrepancy.  
 
Figure 48: Comparing Longitudinal Modulus to Experimental Findings 
Blue represents the elastic modulus' found through experimentation. 
Red represents the theoretical longitudinal modulus calculated using the rule of mixtures. 
 
Table 15: Theoretical Values Using Rule of Mixtures 
Porous 
PVA 
 vf Ef  Em   EL  ET  ER 
Poked 0.03 0 1.2 1.16 0.00 0.44 
Velcro 0.1 0 1.2 1.08 0.00 0.41 
Gas 0.74 0 0.24 0.06 0.00 0.02 
10% salt 0.61 0 0.08 0.03 0.00 0.01 
20% salt 0.31 0 0.24 0.17 0.00 0.06 
2% CS 0.12 65 1.2 8.86 1.36 4.17 
4% CS 0.18 65 1.2 12.68 1.46 5.67 
5% 
CaPO4 
0.16 100 1.2 17.01 1.43 7.27 
10% 
CaPO4 



































Increasing weight percent PVA cryogel showed a decrease in overall swelling 
percent.  10% wt PVA cryogel increased 250% in size while 30% wt PVA cryogel 
increased 197%.  When injecting a dermal filler, a greater swelling rate would lead to a 
smaller sized needle when it is administered to the patient.  Thus, a material such as 10% 






Table 16 relates the parameters for facial implants given in Table 4 in the 
Introduction to the values found of all the PVA cryogel samples.  A green check mark 
indicates that the value of the sample's characteristic is within the range and/or has a 
value closer than current materials on the market.  A red 'X' shows that it did not meet 
this standard. 
The swelling ratio is not shown in the table due to the fact that the test was not 
administered to the porous implants.  Decreasing the weight percent of PVA within the 
hydrogel was shown to increase the swelling ratio.  All weight percents increased in 
volume (250%, 240%, and 197% for 10%, 20%, and 30% wt PVA cryogel) much greater 
than the wanted 50%.  It is a prediction that the porous PVA cryogel weight counterparts 
will have similar volume increases, however more tests will have to be performed to 
determine whether or not this is true.
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Poked    
(30% PVA)
Velcro       
(30% PVA)
Gas           
(20% PVA)
Salt         
(10% PVA)
Salt           
(20% PVA)
2% CS  
(30% PVA)
4% CS  
(30% PVA)
5% CaPO4  
(30% PVA)
10% CaPO4  
(30% PVA)
Adipose Tissue [0.005,0.05] X X ✔ ✔ X X X X X
[0.3,2.3] ✔ ✔ X X X ✔ ✔ ✔ ✔
≥1.71 ✔ ✔ X X X ✔ ✔ ✔ ✔
≥30 ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔
≥2.0 ✔ ✔ X X ✔ ✔ ✔ ✔ ✔
Fibrous [10,30] X X X X X X X ✔ ✔
Bone [100,700] ✔ ✔ ✔ ✔ ✔ ✔ ✔ X X














The pore characteristics were determined from images taken by a Nikon Eclipse 
E600 microscope from sections of the PVA cryogel samples.  The sections were of 
different areas of the samples and images were taken of different areas within the image.  
While these images were taken at areas that had pores similar to the section as a whole, 
the nonumiform nature of the pores could mean the actual average pore size and porosity 
could be larger or smaller than calculated.  In addition, this method was chosen because 
of ease of accessibility to the required machines.  Other methods to determine these 
characteristics found in literature include porosimetry and SEM images.  Porosimetry, 
however would require the extra material in the CS and CaPO4 composited to be 
dissolved out before the test and both machines were not available for use. 
The samples underwent rather crude execution of the testing methods in regards 
to determining their mechanical properties.  As stated above, ASTM standards D412 and 
D624 were followed.  The testing machine utilized was chosen because it was the only 
one that was accessible and tall enough to pull the specimens to their complete length.  It 
did not have auto tightening grips suggested by the standards.  The specimens were 
tightened as much as possible prior to the beginning of the test, then again halfway 
though when the grip of the specimen became loose.  The machine was located in an 
open room not in a temperature controlled air circulation chamber.  The tests specified 
that the specimens should be maintained at 23°C±2 for three days prior.  While they were 
stored at room temperature, no measures were taken to ensure the specified temperature 
during transport or testing nor the desired air flow rate.  While the machine did measure 
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the change in length between the grips, it did not measure the beginning grip length.  This 
was performed using calipers.  The desired thickness for the samples was 3.0±0.3mm.  
As can be seen in Table 6 and Table 8, the thicknesses did not always meet this standard.  
Those that formed within the mold expanded and contracted through the freeze/thaw 
cycles to differing thicknesses.  The salt samples were formed in tubes and after swelling 
in water to leach out the salt and were hand carved to try to give them a shape as similar 
as possible to the desired specifications.  Within the tear test, the nick that had to be cut 
into every specimen was hand done with a scalpel.  The nick depth is specified at 
0.5±0.05mm, however is could have been slightly outside the range due to human error.  
Finally, the standards display their tested accuracy at the end of the documents.  While 
most standard deviations of the characteristics are small, the percent elongation's standard 
deviation was tested to be as high as 50% of its average value.  This shows that a large 
standard deviation for elongation is normal and expected when utilizing this standard. 
The mechanical tests performed on the samples did not simulate the surrounding 
environment they would be in after implantation as well as did not predict long time 
wear.  The ASTM standards require the tests specimens to be maintained at 23°C±2, 
however the average body temperature is about 37°C.  This change in temperature could 
potentially alter the mechanical values determined.  In addition, the CS and CaPO4 
composite materials were not porous during testing.  Porosity will develop in these 
samples after implantation over time as the body absorbs the CS and CaPO4.  Becoming 
porous may change the mechanical properties of the materials as well.  In addition, the 
implants should last indefinitely within the body.  While PVA cryogel is 
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nonbiodegradable within the body, long term influence of the surround tissues and fluid 
was not assessed in these experiments. 
Finally, ASTM F881 requires the hardness of the material be determined with a 
durometer based on ASTM D2240.  This machine, or any compression tool, was 
unavailable for use.  Testing the material's characteristics in compression is needed for 
when predicting the material's overall performance after implantation. Facial implants 
will experience compression forces during daily use, thus the compression characteristics 





Potential Future Work 
Except for the salt samples, the tests performed were on samples that had been 
removed from the mold but were not placed in deionized water and swelled.  Due to the 
chance that they may change, mechanical properties after swelling should be found to 
more accurately determine their values in vivo. 
Another test is to determine cellular ingrowth.  While under the preferred 
conditions such as pore size and the proper surrounding environment, cells should grow 
into the implant.  Tests should be performed to determine the effectiveness of the pores 
on cellular ingrowth. 
The samples were created out of desire to make facial implants, but their use 
could extend into other volume filling implants.  Pores allow them to integrate with the 
body to reduce unwanted movement and prevent extrusion.  Possible examples could 
include current PVA cryogel implants such as cartilage knee replacement to other areas 
such as bone void fillers or breast implants.  Designers should consider porous PVA 




Porous PVA cryogels were shown to be a suitable candidate for the application of 
facial implants.   
Hydrogels manufactured with 30% wt PVA showed an elastic modulus equivalent 
to that of cartilage as well as with other mechanical characteristics.  Pore sizes 
susceptible to the ingrowth of both bone and fibrous tissue were observed as well as 
porosities large enough to encourage attachment.  When looking at all the characteristics 
of the samples as a whole, the PVA/chitosan composites as well as those with altered 
surface finish such as the molded PVA should be considered suitable as an alternative 
material for facial cartilage replacement.  These would be used when there is a need for a 
strong attachment due to bone ingrowth.  For the purpose of fibrous ingrowth, especially 
if there is a desire to later remove the implant, the PVA/CaPO4 composites would be 
suitable.  
In regards to dermal fillers, porous PVA cryogels manufactured with lower PVA 
weights should be considered as alternatives to current injectable materials.  This 
includes gaseous 20% wt PVA cryogel and 10% wt PVA cryogel cast over salt.  Not only 
did these fall within the elastic range of adipose tissue, but samples manufactured with 
lower PVA weights showed higher volume increases when dried then saturated.  The 
porous 10% wt PVA cryogel manufactured with the salt leaching method is 
recommended when a high amount of cellular ingrowth is desired.  A 10% wt PVA 
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